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Even though ultrasound imaging is widely used in clinical diagnosis and image-guided 
interventions, the field is far behind other areas of clinical quantitative image analysis, such as 
MRI, CT and X-ray mammography. In this thesis, non-destructive and non-invasive ultrasound 
characterization techniques were developed to study the tissue micro-structural details using high 
frequency spectral ultrasound imaging (SUSI). The techniques were explored in in-vitro 
conditions of acellular and cellular tissue engineered constructs and then on ex-vivo tissues for 
their characterization. SUSI was used to assess the amount of hydroxyl-apatite (HA) mineral, 
differentiate HA mineral types and study their distribution in acellular tissue engineered 
constructs. The process of mineral deposition from surrounding mineralizing media onto simple 
collagen constructs was also studied and characterized with SUSI. 3D morphological changes of 
the constructs with MC3t3 cells was monitored and characterized for the developmental changes 
such as net cell proliferation/apoptosis and cell differentiation process through mineral 
production by the early osteoblastic MC3t3-cell constructs in-situ. A novel method was 
introduced using SUSI to estimate the amount of mineral secreted by the differentiated osteoblast 
cells in a non-destructive method. Then, SUSI was investigated in ex-vivo cardiac tissues to 
monitor and characterize the cellular changes during high-intensity focused ultrasound ablation 
with high-frame-rate and high-resolution ultrasound imaging. The mechanistic hypotheses 
behind the improvement in lesion detection were investigated and best identification methods to 
assess lesion formation and transient gas body activities were proposed to provide a method for 
xvi 
 
visualizing spatiotemporal evolution of lesion and gas–body activity and for predicting 
macroscopic cavity formation upon its implementation as a real-time monitoring technique with 
feedback control system for HIFU treatment of atrial fibrillation to improve the ablation process. 
Even though the results from the developed techniques show great promise in in-vitro and ex-
vivo settings, additional work needs to be carried out to demonstrate the applicability of the 








Cells, extracellular matrix and growth factors are combined to generate living tissues for 
plausible implants in tissue engineering. Usually, these tissue constructs will be developed in lab 
before administering into the target site, for example at bone fracture sites for faster healing in 
orthopedic applications. To ensure their quality throughout the development time, quantitative 
methods needs to be used to assess the construct state. Traditional methods use histological or 
biochemical assays which are destructive, time consuming, expensive, most of the times can 
analyze only 2D sections and cannot monitor the tissue development due to its destructive 
nature. So, there is a growing demand for non-destructive assessment methods, which can 
characterize physical and microstructural properties quantitatively with the ability to perform 
temporal monitoring, particularly to translate tissue engineering methods into clinic. 
Some of the non-destructive methods in practice include Magnetic Resonance Imaging 
(MRI), Computed Tomography (CT), microscopic imaging and ultrasound. Each of these 
methods have their advantages and disadvantages over other methods. MRI is non-toxic, can 
assess bone mineral density but has low resolution and takes relatively long time for imaging. CT 
has good resolution, can assess bone mineral density but may be toxic and also takes long time 
for imging. Microscopy has high resolution but requires sophisticated procedures to acquire data 
and process them. With microscopy imaging, mainly cell nuclei can be monitored and it is hard 
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to implement the technique in in-vivo. Ultrasound is fast (can be implemented in real-time), 
cheap and non-toxic. Its resolution depends on the imaging frequency and hence can be adapted 
as per the desired application. With high resolution at high imaging frequencies, ultrasound can 
characterize physical and microstructural properties of the tissue. This assessment technique will 
be helpful in non-destructive characterization and monitoring of the tissue samples in lab and for 
in-vivo applications in small animals. Due to the shallow imaging regions at higher frequencies, 
this technique might be limited to fewer specific applications in humans. 
This dissertation addresses practical, non-destructive and non-invasive characterization 
techniques to study the tissue structure using high frequency spectral ultrasound imaging. The 
research is primarily categorized into two sections: developing practical technique to estimate 
tissue scatterer properties and implementing the techniques to identify specific cellular changes. 
Even though the results from the developed techniques show great promise in in-vitro settings, 
additional works needs to be carried out to demonstrate the applicability of the techniques in in-
vivo.  
1.1 Characterization Techniques 
 Even though ultrasound imaging is so widely used in clinical diagnosis and image-guided 
interventions, the field is far behind other areas of clinical quantitative image analysis, such as 
MRI, CT and X-ray mammography. Successful ultrasound characterization methods should 
utilize geometric, temporal, intensity, and imaging physics principles. The choice of which 
constraints to use is in part application specific, but many constraints hold for generic ultrasound 
characterization methods.  
 Characterization of tissues for its structure can be made with B-mode “image” data or 
radiofrequency (RF) data. With access to the raw ultrasound backscattered information in RF 
3 
 
data and availability of high sampling rate of the ultrasound signals, characterization techniques 
with RF data are usually more accurate, reliable and robust compared to B-mode image data. 
Characterization with B-mode images is usually referred as image segmentation techniques 
whereas with RF data as quantitative ultrasound (QUS) characterization techniques.  
 Most basic and fastest QUS characterization techniques are usually in the time/space 
domain of the ultrasound signal. Simplest technique being thresholding the envelope of the RF 
backscattered signal in applications where high contrast in the tissue segment of interest 
compared to the other regions is observed. Since most of the applications doesn’t show high 
contrast, more detailed characterization techniques were used. Measurements of ultrasonic 
attenuation have been helpful in identifying diffuse liver disease and benign conditions in the 
breast [1, 2]. Attenuation estimation methods can be classified as either time or frequency-
domain approaches [3-5]. Video or B-mode signal analysis methods were developed by Knipp 
et al. [6] to estimate attenuation directly from B-mode images.  
 Acoustic radiation force impulse (ARFI) imaging is a radiation force-based imaging 
method that provides information about the local mechanical properties of tissue [7-9]. ARFI 
imaging uses short-duration acoustic radiation forces to generate localized displacements in 
tissue, and these displacements are tracked using ultrasonic correlation-based methods. The 
tissue response to these forces can be monitored both spatially and temporally. Displacement 
magnitude is inversely proportional to local tissue stiffness. In this method, a single transducer 
on a diagnostic ultrasound (US) system can be used to both apply localized radiation forces 
within tissue for short time periods and to track the resulting tissue displacements. The use of a 
single transducer guarantees both alignment and ease of clinical implementation, as well as 
facilitating real-time implementation. ARFI imaging has many potential clinical applications, 
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including detecting and characterizing a wide variety of soft tissue lesions, and identifying and 
characterizing atherosclerosis, plaque and thromboses. 
Backscattered ultrasound signals can be modeled as the sum of the contributions from 
individual scatterers within the range of the pulse echo (the resolution cell). Thus, the statistical 
distribution of the backscattered ultrasound signal is related to the number of scatterers per 
resolution cell and their arrangement within the resolution cell. Analysis of this statistical 
distribution may be used for tissue characterization. Rayleigh, Rician, K, and Nakagami 
distributions all have been used for tissue characterization [10-12]. For example, Shankar et al. 
[13, 14] demonstrated the usefulness of the K and Nakagami distributions for classifying benign 
and malignant breast tumors. The statistical distribution of the backscattered signal from 
myocardial tissue also has been characterized by several investigators [15, 16]. Clifford et al. 
[15] tested five statistical models (K, Rician, Rayleigh, Nakagami, and lognormal distributions) 
for description of normal myocardial tissue. 
Some ultrasonic tissue characterization techniques generally consider frequency 
dependent information of backscatter echoes to quantify tissue structural properties, such as the 
size, acoustic impedance, number density of scattering particles, etc. This approach has been 
successfully used for the characterization of the eye [17, 18], liver [19], kidney [20], prostate 
[21], breast tissues [22] and also to monitor cell apoptosis in order to evaluate the efficacy of 
cancer therapies [23]. 
1.2 Spectral Ultrasound Imaging 
Conventional B-mode ultrasound imaging is based purely on gray scale values and is able 
to provide spatial and temporal information about sample morphology. However it provides little 
direct information about sample composition. A key drawback of purely gray scale analysis is 
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that the image signal is dependent on a variety of factors including ultrasound transducer 
response and image post-processing. The results are therefore operator- and system-dependent, 
and it is difficult to compare data taken on different imaging systems or at different times in an 
objective and meaningful fashion. In contrast, spectral ultrasound imaging (SUSI) utilizes 
unprocessed, raw backscattered radiofrequency (RF) signals. 
Studies carried out mostly over the last few years used high-frequency (10 to 60 MHz) 
ultrasound to investigate backscattering properties of cell aggregates, which were used as 
simplified models of tumors [23, 24]. In this regime, wavelengths (25 to 150 μ m) approach the 
size (10 to 20 μ m) of the cells or nuclei and exhibit much more sensitivity to cell structure and 
changes in cell structure during cell death compared with the lower interrogating frequency 
range (<10 MHz) available with conventional ultrasound imaging systems [23]. This observation 
suggests that the high-frequency ultrasound backscattering technique can be used to detect cell 
apoptosis and also to monitor efficacy of cancer treatments [25]. 
Kolios et al. [24] used an ultrasound spectral analysis method to analyze measured 
ultrasound signals from cell ensembles treated with chemotherapeutics and also from aggregates 
of healthy cells. They found that ultrasound backscatter intensity and spectral slope increased 
because of treatment and that was interpreted as a consequence of the decrease in effective 
scatterer size. Similarly, Vlad et al. [23] experimentally investigated how backscattering 
properties for several cell lines vary with time after radiotherapy, and consequently examined the 
potential of this technique to differentiate various types of cell death. Tunis et al. [26] studied the 
envelope statistics of ultrasound backscatter signals from cisplatin-treated aggregated acute 
myeloid leukemia (AML) cells and evaluated the applicability of various statistical distribution 
functions to model the envelope histograms. They reported that shape parameters of the 
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generalized gamma distribution function were sensitive to the structural changes within cells 
induced by the drug. Oelze et al. [22] also used high-frequency ultrasound to differentiate and 
characterize rat mammary fibroadenomas and 4T1 mouse carcinomas. They generated 
quantitative ultrasound (QUS) images based on the estimated scatterer properties (scatterer 
diameter, acoustic concentration). These properties were obtained by analyzing backscatter 
signals in the spectral domain and by employing a Gaussian form factor model [20]. They 
showed that QUS images are capable of distinguishing two types of tumors. In another 
investigation [10], the same group examined carcinoma and sarcoma in mouse models using 
QUS. It was observed that the estimated parameters extracted from the frequency band 10 to 25 
MHz cannot distinguish between the two kinds of tumors, but those of 16 to 25 MHz can clearly 
show some differences. 
Spectral parameters have also proven to be effective for identifying changes in tissue 
state for prostate, breast and other cancer tissues [22, 27] as well as intravascular plaque [28-30]. 
Thus, SUSI can be used as an effective tool to characterize several tissues for their composition 
and structure including assessment of tissue engineered constructs. 
1.3 Ultrasound in Tissue Engineering 
Ultrasound imaging has shown promise for rapid and nondestructive imaging in tissue 
engineering. In particular, ultrasound has been used to characterize the evolution of tissue 
components and corresponding changes in tissue properties in a variety of systems. For example, 
attenuation of gray scale (B-mode) ultrasound signals over time has been shown to correlate with 
matrix deposition and differentiation of adipose stem cells on synthetic scaffolds [31]. Similarly, 
gray scale signals have been used to assess collagen production by myofibroblasts in 3D fibrin 
matrices over time [32]. Kreitz et al. tracked collagen deposition by myofibroblasts in fibrin 
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tissue constructs over an 18 day culture period.[33] Their quantitative analysis of observed gray 
scale values were correlated to ECM deposition as measured by hydroxyproline content. 
Acoustic parameters have also been correlated to the mechanical properties and cartilage matrix 
evolution by chondrocytes in polyethylene glycol hydrogels [34] and have been used 
characterize the mechanical properties of agarose hydrogels as they develop over time [35]. 
Ultrasound has also been used as a non-destructive method to quantify the actual number of cells 
in BMSC/β-TCP composites by grayscale equivalent parameter [36]. Not many studies have 
been done in assessing tissue engineered construct for cell size, concentration and construct 
composition. SUSI may therefore have utility in more fully characterizing the composition of 
engineered tissues. 
1.4 Atrial Fibrillation 
Atrial fibrillation is the most common cardiac arrhythmia and its current clinical 
treatment procedures can use real-time monitoring techniques to improve the efficiency of the 
treatment. One of the able treatments is high intensity focused ultrasound (HIFU) [37] and its 
monitoring during the treatment is not well established. A section of the current study aims to 
establish methods to monitor HIFU ablation process in real-time in ex-vivo cardiac tissues to 
determine the lesion extent and gas-body activities.  The formation and extent of HIFU-induced 
tissue necrosis, or thermal lesion, is determined by the spatiotemporal distribution of 
temperature-increase induced by HIFU exposure [38, 39].To achieve better control of the 
ablation process, robust and effective imaging methods are needed for real-time monitoring of 
tissue changes such as lesion formation during HIFU application. Magnetic resonance imaging 
(MRI) has been valuable in guiding and monitoring HIFU ablations [40-42] in real-time with 
spatial and temporal control on temperature rise in the tissue induced by HIFU. While magnetic 
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resonance imaging (MRI) [40] and x-ray computed tomography (CT) [43] have been used as 
effective image guidance during ablation, monitoring with diagnostic ultrasound imaging has the 
advantage of relatively lower cost, higher portability, and high spatiotemporal resolution.  
A variety of ultrasound imaging techniques beyond conventional grayscale B-mode 
imaging has been developed to detect tissue changes. For example, ultrasound tracking of echo 
shifts [44-46] or changes in ultrasound backscatter [47, 48] have been used to monitor 
temperature changes during HIFU ablation. Ultrasound elastography has been used to evaluate 
tissue necrosis [8, 9, 49, 50] as thermal lesions exhibit increased stiffness, but lesion 
characterization via elastographic imaging is subject to degradation in the presence of gas bodies 
[51]. 
HIFU ablation induced changes in attenuation [52-54] and ultrasound backscatter [53-55] 
were used to detect changes in tissue state. Integrated backscatter changes to monitor HIFU 
lesion formation have been studied in ex vivo bovine liver at an imaging frequency of 7.5 MHz 
[53, 54]. Tadpole-shaped lesions showed an increase in differential attenuation of up to 
3.5 dB/MHz/cm and increase in accumulated differential integrated backscatter (IBS) of up to 
25–30 dB, although more precise definition of the lesion was obtained with the differential IBS 
image. 
Echo decorrelation has been proposed as a means to identify lesion formation in 
radiofrequency (RF) ablation, with the potential benefits of reduced sensitivity to acoustic 
shadowing and tissue motion as compared to other methods [56]. Mapping and characterization 
of RF ablated lesions in ex vivo liver tissue with temporal maximum decorrelation showed good 
performance when compared to temporal maximum IBS using backscattered RF data from B-
mode ultrasound imaging [56, 57]. 
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Spectral parameters of the backscattered RF ultrasound data, which are related to tissue 
properties like effective acoustic scatterer size and concentration [58], have also been shown to 
change as a result of HIFU exposure. Lesions induced by HIFU in ex vivo chicken breast and 
rabbit liver showed increased midband fit of 6 to 8 dB compared to surrounding non-ablated 
tissue [58, 59]. These increases are likely due to the increased backscatter from gas bodies 
induced by HIFU exposure in the focal region and changes in effective scatterer size due to 
coagulative necrosis. Spectral parameters have also been computed to characterize lesions 
induced by RF ablation in ex vivo bovine liver [60]. 
Although a variety of methods have been proposed to improve ultrasound imaging of 
HIFU ablation and lesion formation, ultrasound imaging has not yet been established as a robust 
and consistent technique. 
1.5 Organization of Thesis 
A detailed theory and analysis of spectral ultrasound with methods to estimate scatterer 
size and concentration are presented in Chapter 2. The theory was verified with experiments on 
polybead phantoms to validate the polybead diameter and concentration estimation using spectral 
ultrasound imaging (SUSI).  
SUSI is then used to assess the amount of mineral content in acellular tissue engineered 
constructs in Chapter 3. Spectral parameters in differentiating and characterizing different 
mineral types seeded in collagen construct were investigated. The process of mineral deposition 
from surrounding fluid medium onto simple collagen constructs was studied and the amount of 
mineral deposition was characterized with SUSI. 
Chapter 4 focuses on providing high resolution ultrasound as an imaging modality in the 
field of tissue engineering to monitor the 3D morphological changes of the constructs online and 
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to characterize the development changes which include net cell proliferation/apoptosis and cell 
differentiation process through mineral production estimation of the early osteoblastic MC3t3-
cell constructs in-situ in a non-destructive method. 
The ability of high-frame-rate and high-resolution imaging to monitor lesion formation 
and gas-body activity during high-intensity focused ultrasound (HIFU) was examined in Chapter 
5. The mechanistic hypotheses behind the improvement in lesion detection were investigated and 
a best identification method to assess lesion formation was proposed. Transient gas-body activity 
was identified and tracked. These assessments provide a method for visualizing spatiotemporal 
evolution of lesion and gas–body activity and for predicting macroscopic cavity formation and 
can be implemented as real-time monitoring with feedback control system for HIFU treatment of 
atrial fibrillation to improve the ablation process. 
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Spectral Ultrasound Imaging 
 
 
High-frequency ultrasound research is attracting considerable interest because its short 
wavelengths (e.g., 50 µm at 30 MHz) and small focal-zone beam diameters provide fine-
resolution images. Quantitative ultrasound (QUS) imaging is being investigated by several 
research groups and many tissue parameters have been estimated. This chapter focuses on one 
such QUS method that incorporate spectrum analysis of high frequency ultrasound, radio-
frequency (RF) echo signals.  
2.1 Introduction 
Spectral analysis of ultrasound RF signals is derived from the theoretical framework of 
ultrasound scattering established by Lizzi et al. [1] for biologic tissues and subsequently 
expanded by him and others (Oelze et al. [2]; Insana et al. [3]; Mamou et al. [4]; Oelze and 
Zachary [5]). Frequency-dependent information derived from RF backscattered signals [2, 3, 6] 
was used to quantitatively assess tissue microstructural properties and relate them to histologic 
properties. Some fundamental high-frequency QUS studies already have been conducted on 
microspheres and suspended cells [7] and cells in pellets to try to quantify apoptosis [8]. 
Microspheres and single-cell experiments showed agreement between experimentally- and 
theoretically-derived backscatter coefficients. In particular, backscatter reflection coefficient 
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resonances predicted by theory were observed experimentally. The results of the apoptosis study 
also suggested that spectral slope and mid-band fit changed as a function of time in cells treated 
with an apoptosis-inducing drug.  
Our group successfully used spectrum-analysis methods at 6 MHz to show distinct 
differences between normal and diseased pancreas and lymph nodes. More recently, interest has 
grown in applying QUS methods using high frequency ultrasound because higher frequencies 
can evaluate the tissue with finer resolution than lower frequencies. An empirical criterion states 
that QUS methods are most sensitive to structures for which kD ≈ 2 [3], where k is the wave 
number and D is a typical size or dimension of the scattering structures. For example, operating 
at 55 MHz, i.e., k = 0.23 µm
-1
, leads to D = 8.7 µm in tissue. Hence, higher frequencies allow 
correlating QUS estimates with tissue microstructure on a finer scale [4, 5, 9, 10]. Therefore, our 
hypothesis is that QUS estimates at 55 MHz ultrasound imaging may resolve the tissue structure 
to finer details and may let study tissue changes via HIFU ablation or tissue development process 
in a great detail.  
2.2 Methods 
2.2.1 Phantom Preparation 
 Agar phantoms with Polybead® microspheres (Polysciences, Inc.) of different bead 
diameters at various concentrations were used in this study. Polybeads were added to the 2% 
agar solution at 45
0
 C and thoroughly mixed to disperse the polybeads uniformly throughout the 
phantom. Four polybead diameters, 6, 10, 16 and 25 µm that are of interest were chosen. For 
each polybead size, phantoms with four different concentrations of polybeads were made. Each 
phantom was approximately 2000 mm
3
 in size.   
2.2.2 Ultrasound Imaging and Data Acquisition 
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Figure 2.1 shows a schematic diagram of the imaging setup that includes a 90 mm 
diameter Petri dish filled with distilled water at room temperature. Phantoms were placed on top 
of an agar gel pad, which reduces the reflection from the bottom of the dish. Ultrasound imaging 
was performed with a Vevo 770 (VisualSonics Inc., Toronto, Canada) using an RMV 708 
imaging probe with a nominal 55 MHz center frequency, 20-75 MHz bandwidth (−6 dB), 4.5 
mm focal distance, and 1.5 mm depth of focus (−6 dB). 3D backscattered RF data from the 
phantom were collected at either 100% or 50% scanner power and 420 MS/s by performing 
multiple B-mode scans using an automatic 3D translational controller. The interval between 
adjacent A-lines and B-mode scans were 31 μm and 64 μm, respectively. After each RF 
acquisition of a construct, a reference RF acquisition of the setup without the construct was 
collected, for phantom attenuation estimation. 
 
Figure 2.1 Schematic of experimental setup used for spectral ultrasound imaging of phantom. 
2.2.3 Analysis 
Theoretical frameworks that relate ultrasound spectral parameters to scatterer properties 
were developed by Lizzi and Insana [1, 3]. These frameworks make several critical assumptions, 
some of the key assumptions being (1) randomly but statistically uniformly distributed scatterers 
in space, (2) effective diameters of the scatterers are much smaller than -3 dB beamwidth  (3) 
weak scattering, (4) weakly focused transducer, (5) scattering is isotropic and to occur at or 
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beyond the focal region of the transducer.  With these assumptions, the spectra (in dB) from 
small isotropic scatterers will have the form,  
        
21 0
ln 1 0
2 22 ( 1 )
' ln ln 5 2 .8 ln
n
a af QE n f CS f
    
 
 (2.1) 
where f is in MHz, a is in mm, C is the # concentration of the scatterers in #/mm
3
, Q is the 
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Linear regression analysis is applied to the spectra to estimate the spectral parameters. The 
expressions for slope (m) and mid-band fit (M) are:  
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where f1 and f2 are the minimum and maximum frequencies in the bandwidth and fc is the center 
frequency. After algebraic simplification,  
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The spectral intercept can be evaluated by using the expression, I = M - mfM, where fM is the mid-
band fit frequency in MHz.  
2.2.3.1 Scatterer Size 
The spectral parameters were corrected for the attenuation (α, dB/(cm-MHz)) of the 
tissue construct as m=m+2αz and M=M+2αzfM  where z is the ultrasound propagation distance in 
the tissue construct until the spectral cell. The scatterer radius can be calculated using: 
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2.2.3.2 Scatterer Concentration 
With known value of Q, Eq. (2.8) can be rearranged to solve for C, 

















  (2.14) 
Relative acoustic impedance, Q, of MC3T3 cells is estimated from various known # 
concentration, C, of the cells and is then used in the cell differentiation study to estimate C.  
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2.3 Results and Discussion 
2.3.1 Analytical Results 
 
Figure 2.2 Analytical predictions of linear regression spectral parameters (A) Slope, (B) Mid-band Fit 
and (C) Intercept with diameter at different central frequencies. (D-F) are the corresponding parameter 
variations with acoustic concentration on a log scale at 6, 10, 16 and 25 µm scatterer diameters. 
The relation between the spectral parameters and the tissue properties are shown in Eqs 
(2.13) and (2.14). For a given ultrasound imaging system, the slope depends only on the scatterer 
radius, a. For very small a, only the first term is significant in Eq. (2.7). As a increases, the slope 
decreases in proportion to a
2
 for all scatterer types. Representative behavior of slope dependence 
on scatterer radius is shown in Figure 2.2A for isotropic scatterers at different transducer center 
frequencies with 100% fractional bandwidth. As the center frequency increases, the spectral 
slope varies more significantly with scatterer radius, hence a better contrast is obtained with high 
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center frequency of the transducer in characterizing scatterers of different sizes. The independent 
behavior of slope with acoustic concentration is seen in Figure 2.2D. 
 
Figure 2.3 3D backscattered images (left panel) and B-mode images (right panel) of the 6, 10, 16 and 25 
µm diameter polybead phantoms. 
The variation of M with CQ
2
 at different scatterer radii are shown in Figure 2.2B for 
various transducer center frequencies. As the frequency increases, the dependence of M on 
scatterer diameter becomes convex in nature. From the Eq. (2.8), M varies linearly with log(CQ
2
) 
for a certain scatterer diameter and can be seen in Figure 2.2E. The intercept increases 
significantly with scatterer diameter for D > 20 µm for transducers with high center frequencies 
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(Figure 2.2C). The intercept doesn’t show any convex nature with scatterer diameter and 
increases with increase in diameter due to increased backscattering. Even the intercept varies 
linearly with log(CQ
2
) for a certain scatterer diameter, Figure 2.2F.  
2.3.2 Phantom Results 
 
Figure 2.4 3D backscattered images (left panel) and B-mode images (right panel) of the 6 µm diameter 







Ultrasound backscattered 3D and B-mode images of 6, 10, 16 and 25 µm diameter 
polybead phantoms are shown in Figure 2.3. The contrast in the size of the polybeads across 
these phantom B-mode images is a bit evident along with the increased backscattering strength  
as the polybead size increases. B-mode images of 6 µm diameter polybead phantoms at 4 
different polybead concentrations are shown in Figure 2.4 with an evidently increased 
backscattering strength with polybead concentration. 
 
Figure 2.5 Estimated diameter against estimated concentration for (A) 6 µm, (B) 10 µm, (C) 16 µm and 
(D) 25 µm diameter polybead phantoms at 4 different concentrations. True/Predicted values are indicated 
by points and the estimated values by errorbars. 
With known speed of sound & density of Agar and polybeads, 1480 m/s & 1000 kg/m
3
 
and 2350 m/s & 1060 kg/m
3 
respectively, the relative acoustic impedance of the phantoms was 
estimated as 0.68. The spectral parameters were estimated and the microstructural properties, 
size and concentration of the polybeads are shown in Figure 2.5. The concentration of the beads 
increases from blue to red. The predicted values are represented by points with markers whereas 
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the estimated values by errorbars with markers. The estimated spectral parameters track the 
theoretically predicted values well. The mean percentage errors in size and concentration 
estimations were 7% and 14% respectively. Relatively higher percentage error in concentration 
estimations from the predicted values might be due to any local inhomogeneous spatial 
distribution of the polybeads and any clustering of the polybeads. For each scatterer size, spectral 
slope is a horizontal line w.r.t concentration, C, of the beads indicating its non-dependence 
nature on C. As the size increases, the spectral slope decreases due to its inverse dependence. M 
and I showed a linear relationship with log(C), similar to the ones in Figure 2.2E and 2.2F. 
Again, the intercept values show a constant increase with bead diameter due to increased 
backscattering strength. The diameter estimation is non-dependent on concentration as expected. 
2.4 Conclusion 
 Spectral parameters obtained from polybead phantom experiments show good agreement 
with those predicted by the theory. This successful estimation will provide a better means for 
determining tissue-scatterer properties. These preliminary studies show promise for establishing 
an extended framework that will be useful for quantitatively assessing tissue architecture to 
diagnose HIFU ablation process, characterize the mineral content in acellular constructs and to 
monitor cell differentiation process in MC3t3 constructs, discussed in later chapters. 
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The objective is to correlate the amount of mineral present in the constructs with 
ultrasound parameters. The spectrum of the ultrasound backscattered signals contains the 
information about physical and acoustic properties of the scatterer (mineral) and is exploited to 
determine the size and concentration of the mineral in the construct. First, acellular collagen 
hydrogels were prepared and imaged using ultrasound to observe its scattering properties. Then, 
hydroxyl-apatite (HA) mineral was added to the collagen hydrogel during the preparation 
process. Three different types of HA minerals varying in their mineral size were chosen to 
observe their distribution and scattering properties under ultrasound. Sonication, a process of 
mixing and fragmentation of clusters into smaller particles, was applied on the HA mineral 
before it is added to the construct to improve the distribution of HA mineral in the construct. 
Once the type of HA mineral that is  distributed uniformly within the construct and the effect of 
sonication in improving the distribution are determined using the ultrasound, constructs were 
made with that chosen HA type at three different densities to characterize its amount using 
ultrasound parameters. Next, the process of mineral deposition from surrounding fluid medium 
onto simple collagen constructs was studied. When a collagen construct is placed in a medium 
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containing minerals, the mineral present in the fluid medium will start depositing on the 
construct due to the concentration difference of the mineral. The rate of mineral deposition on 
the construct depends on the concentration of the minerals in the medium and whether the 
minerals are in supersaturated state or in dissolved state at a certain temperature. With PBS, 2.5x 
SBF and 5x SBF as media, the changes in morphology, the amount of calcium deposited on the 
construct was studied over time and the later was compared with spectral mid-band fit parameter 
for correlation. The results from this study are published in “Tissue Engineering Part C: 
Methods”, volume 18, issue 12, 2012 with the title, “Non-invasive, Quantitative, Spatiotemporal 
Characterization of Mineralization in Three-Dimensional Collagen Hydrogels using High-
Resolution Spectral Ultrasound Imaging” [1]. 
3.1 Materials and Methods 
The tissue constructs were manufactured in Cell-Matrix Interactions & Tissue 
Engineering (CMITE) lab, Department of Biomedical Engineering.  
3.1.1 3D Collagen Hydrogel Fabrication 
Collagen type I (MP Biomedicals, Solon OH) was dissolved at 4.0 mg/ml in cold 0.02 N 
acetic acid overnight. Constructs were created [2] by mixing 10% fetal bovine serum, 10% 1x 
Dulbecco’s modified Eagle’s medium (DMEM), 20% 5x DMEM, 10% 0.1 N NaOH and 50% 
solubilized collagen (obtained solubilizing 4 mg/ml collagen type I in 0.02 N acetic acid 
overnight) at 4C for a final collagen concentration of 2 mg/ml. The mixture (500 µl) was then 
injected into a 24 well plate and allowed to gel at 37C for 45 mins. 
3.1.2 Addition of Hydroxyapatite to 3D Hydrogels 
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Composite collagen-hydroxyapatite (HA) hydrogels were fabricated by adding particulate 
HA directly to the gel mixture. Three types of hydroxyapatite, reagent-grade (HA-R; Sigma), 
micro- (HA-M; Plasma Biotal Ltd.), and nano- (HA-N; Sigma), were incorporated within 
collagen gels. The average size diameter of the HA sources were 590 µm, 5 µm, and less than 
200 nm, for HA-R, HA-M, and HA-N, respectively. HA solution stock of 200 mg/ml HA in 1x 
DMEM was prepared and autoclaved at 120°C for 20 minutes to maintain sterility. A 10 mg/ml 
collagen-HA hydrogel was fabricated by adding 5% HA-stock, 5% 1x DMEM, 10% FBS, 20% 
5x DMEM, 10% 0.1 N NaOH, and 50% collagen and gelation was initiated as described earlier. 
Other concentrations of composite collagen-HA hydrogels were created by adding or diluting the 
stock HA by the appropriate factors to fabricate tissue constructs with 5 mg/ml and 20 mg/ml 
HA. For dispersion studies, stock HA and 1x DMEM (10% of final gel) were mixed at 4C and 
placed in a water-bath sonicator for 1 hour to disrupt particle aggregates. The HA-DMEM 
mixture was then added immediately to the collagen pre-gel mixture and gelation was initiated as 
previously described. 
3.1.3 Mineralization in Simulated Body Fluid 
Prepared simulated body fluid (SBF) [3] had final ion concentrations of 141 mM NaCl, 4 
mM KCl, 2.5 mM CaCl2-H2O, 1 mM MgCl2, 4.2 mM NaHCO3, 0.8 mM MgSO4, and 1 mM 
KH2PO4 . Solutions of 2.5x and 5x SBF were prepared by increasing the concentrations of each 
reagent by the necessary factor. Collagen hydrogels were fabricated as described previously and 
incubated at 37C in either PBS, 2.5x SBF, or 5x SBF. Samples were imaged at days 3, 7, 10, 14, 
and 21. Calcium deposited on collagen hydrogels after incubation in PBS, 2.5x SBF, and 5x SBF 
was quantified experimentally at days 3, 7, 10, 14, and 21 using an orthocresolphthalein 
complex-one (OCPC) method [4]. 
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3.1.4 Ultrasound Imaging and Data Acquisition 
Figure 3.1 [1] shows a schematic diagram of the imaging setup that includes a 90 mm 
diameter Petri dish filled with PBS at room temperature. Collagen constructs were placed on top 
of an agar gel pad, which reduces the reflection from the bottom of the dish. Ultrasound imaging 
was performed with a Vevo 770 (VisualSonics Inc., Toronto, Canada) using an RMV 708 
imaging probe with a nominal 55 MHz center frequency, 20-75 MHz bandwidth (−6 dB), 4.5 
mm focal distance, and 1.5 mm depth of focus (−6 dB). 3D backscattered RF data from the tissue 
construct were collected at either 100% or 10% scanner power and 420 MS/s by performing 
multiple B-mode scans using an automatic 3D translational controller. The interval between 
adjacent A-lines and B-mode scans were 31 μm and 64 μm, respectively. After each RF 
acquisition of a construct, a reference RF acquisition of the setup without the construct was 
collected. 
 
Figure 3.1 Schematic of experimental setup used for spectral ultrasound imaging of tissue construct. 
3.1.5 Data Analysis 
With known speed of sound in the surrounding fluid medium  fC , the thickness of the 
construct can be found using    
re f c o n s tru c t
f b o tto m to p p a d p a d




t  is the time 
of arrival of the ultrasound pulse at the construct’s top surface, 
b o t to m
t  at the bottom surface, 
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c o n s tru c t
p a d
t  at the bottom reflector with construct and r e f
p a d
t  at the bottom reflector without the 
construct. The speed of sound in the construct can then be evaluated using 
 
c o n s tr u c t
b o tto m to p






GS and spectral parameters were calculated on the 3D RF data of the construct. The 
density of analysis parameters were calculated as V
X d V
X D e n s ity
V

 , where X is either GS or 
spectral parameters evaluated in volume V of the tissue construct. In case of signal saturation, the 
time windows in which the signal is saturated are discarded in the analysis process. The 
ultrasound backscattering from collagen construct alone (without mineral) was very poor and its 
mean GS value in 0.1 μs time window is very close to that of backscattering from fluid medium. 
A threshold GS value based on collagen construct for determining the mineral lacking regions in 
the construct was obtained. Any analysis in this region would be uninformative due to poor 
scattering and hence are discarded from the analysis process.  
3.1.6 Statistical Analysis 
 Analysis was carried out on a 0.5 mm x 5.0 mm x thickness (~2 mm) volume of each 
construct and the data are presented as mean ± standard deviation. Statistical comparisons 
between any two parameters were made using Student’s t-test for paired samples and the 
differences were considered significant at a level of p<0.05. 
3.2 Results 
3.2.1 Virtual Histology 
 The setup used in this study allowed rapid and noninvasive 3D imaging of collagen 
constructs while still in incubating culture medium. Image acquisition was completed in a few 
seconds at a frame rate of 45 Hz, and saving of the raw RF data required 2-3 minutes. In the 
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present study, construct boundaries were determined manually based on GS thresholding, though 
this process could be automated and accelerated in the future. Overall, analysis of each construct 
using SUSI required about 5-10 minutes. 
 
Figure 3.2 Virtual histology of 3D collagen constructs. Panels A-F show a collagen construct with added 
HA-N mineral, and panels G-L show corresponding images of a pure collagen control construct. (A, G) 
Color images of the top view of constructs. (B, H) 3D ultrasound rendered image of the section 
represented by white dotted box in A and G. (C, I) Ultrasound C-scans of a transverse xy-plane. (D, J) 
Grayscale (GS), (E, K) mid-band fit (MBF) and (F, L) slope images of one section in the xz-plane. 
Figure 3.2 [1] shows a representative example of ultrasound imaging and analysis output 
from a collagen hydrogel containing HA-N mineral (Fig 2A-2F), as well as a “control” construct 
of pure collagen (Fig 3.2G-3.2L). The photographs of the construct (Fig. 2A, 2G) show a top 
view (xy-plane) and the region that was imaged is indicated by the dotted rectangle. The 3D 
volume-rendered ultrasound images (Fig. 3.2B, 3.2H) show the overall dimension and 
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morphology of the construct. This digital reconstruction can be rotated and/or sectioned to 
provide any desired viewing prospective. Figure 3.2C is an image in the xy-plane at a defined 
depth (known as a C-scan) of the 3D of the HA-N construct, and shows homogeneous speckles 
indicative of uniform spatial distribution of mineral in the construct. Similarly, a GS image in an 
xz-plane of the HA-N construct (Fig. 3.2D) shows a mainly homogeneous distribution of mineral 
in the lateral (x) and depth (z) directions, as well as evidence of mineral settling at the bottom of 
the construct. The corresponding MBF image of the calibrated RF power spectrum (Fig. 3.2E), 
which is related to scatterer radius and concentration in the construct, shows an increasing 
concentration of scatterer toward the bottom of the HA-N construct. In contrast, the slope 
parameter (Fig. 3.2F), which varies inversely with scatterer radius, is relatively homogeneous in 
the bulk of the HA-N construct but decreases near the bottom of the construct, indicating settling 
of larger particles or cluster formation by the mineral. The corresponding rendered and RF 
spectrum images for the control construct (Fig 3.2H-3.2L) show very little signal, demonstrating 
that SUSI can discriminate between mineral-containing and pure collagen materials. 
3.2.2 HA mineral sources and effect of sonication 
Three different types of HA mineral sources of same concentration (10 mg/ml) were 
added in the collagen hydrogels to characterize the type of HA mineral source using ultrasound 
imaging. Sonication of the mineral during the construct manufacturing process was performed to 
observe its effect on distribution of the mineral in the construct. Each column of Fig. 3.3 [1] 
shows parametric images (3D rendered, GS and spectral parameters) for each type of HA source 
(R, M and N). The bottom half images of the figure contrasts the effect of sonication with 
unsonicated constructs in the top half images. The left half of Fig. 3.3Bi and 3.3Ei (i = 1, 2 and 3) 
shows GS and right half shows MBF. Similarly, left half of Fig. 3.3Ci and 3.3Fi shows GS and 
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right half shows slope. In spectral analysis and graphic representation, pixels with very low 
scattering (locations of mineral lacking collagen) and saturated RF data were not analyzed and 
represented. Higher backscattering at the bottom layer of the construct is due to the settling of 
HA mineral and is high in HA-R compared to HA-M and HA-N due to its larger particle size and 
weight. Being smaller in size, HA-N is distributed more uniformly throughout the construct 
compared to HA-M and HA-R. 
 
Figure 3.3 Parametric images (Ai through Fi) of collagen constructs with 3 different HA sources: R (i = 
1), M (i = 2) and N (i = 3). (Ai) 3D rendered image of the construct. (Bi) Left half shows GS image and 
right half shows MBF image in one frame at mineral spotted locations excluding the saturated RF data at 
the bottom mineral layer. Similarly, right half of (Ci) shows spectral slope image. Constructs with 




Figure 3.4 Histogram distributions of volume occupied by the mineral spotted with GS/MBF/Slope 
parameters: (A1) Comparison of Grayscale (GS) distributions of unsonicated HA-R (blue), M (black) and 
N (red) constructs. Ai=2,3,4 shows comparison between distributions of sonicated (thick) and unsonicated 
(thin) constructs for HA type R, M and N respectively.  Similar comparisons using mid-band fit (MBF) 
and spectral slope parameters are shown in Bi=1,2,3,4 and Ci=1,2,3,4 respectively. 
Sonication process during construct manufacturing increased the distribution of HA mineral, 
particularly in HA-R (Fig. 3.3E1 vs. 3.3B1). GS, MBF and slope parameters were calculated on 
construct volume of 0.5 mm x 5 mm x thickness (~2 mm) for each HA type and process 
(unsonicated vs. sonicated). The histograms were constructed against the volume occupied by the 
mineral at parameter values. Higher area under the curve of the histogram and higher mean of 
the distribution in Fig. 3.4A1 and 3.4B1 (unsonicated HA-R, M and N) is a correspondence of 
homogeneous distribution of the mineral in the construct. Lower mean of slope for HA-R in Fig. 
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3.4C1 correlated to its large particle size. The mean of slope for HA-M and N are very close, 
possibly due to the limit of the employed ultrasound probe unable to determine the small particle 





 columns for each HA source. Sonication improved the distribution of HA-
R quite significantly and small improvement was observed in HA-M and N also. 
Table 3.1 Mean and standard deviation of ultrasound parameters correspondence of HA mineral. (n=4 for 
each sample type) 
Process Parameter  
HA mineral type 
R (µ ± σ) M (µ ± σ) N (µ ± σ) 
Unsonicated 
GS (dB) 1.24 ± 0.33 1.45 ± 0.32 1.59 ± 0.39 
MBF (dB) -72.2 ± 6.1 -69.8 ± 4.2 -67.4 ± 5.5 
Slope (dB/MHz) 0.20 ± 0.18  0.33 ± 0.16  0.37 ± 0.17  
Sonicated 
GS (dB) 1.68 ± 0.38 1.61 ± 0.37 1.73 ± 0.36 
MBF (dB) -66.0 ± 5.1 -67.1 ± 5.6 -65.0 ± 4.9 
Slope (dB/MHz) 0.39 ± 0.17  0.38 ± 0.16  0.40 ± 0.16  
 
3.2.3 Characterization of HA mineral density 
HA-N mineral distributed more uniformly compared to HA-R and M and was chosen to 
characterize its concentration (or density) in the construct. Constructs with HA-N of 3 different 
concentrations (5, 10 and 20 mg/ml, n = 4 for each) were manufactured and imaged. Figure 3.5 
[1] shows 3D renderings as well as GS, MBF and slope data for these constructs. The intensity of 
both the GS and MBF signals reflect the increasing HA content, while the slope values remain 
essentially unchanged. These data reflect that while the amount of HA in the constructs 




Figure 3.5 Ultrasound imaging of collagen-HA constructs made with three different concentrations of 
HA-N with sonication. First column shows 3D rendered images, second column shows GS and 
superimposed MBF, third column shows GS and superimposed slope. Rows show the HA-N 
concentration used to make the constructs. 
 
Figure 3.6 Correlation of sonicated HA-N mineral density with (A) GS density and (B) MBF density (C) 
Slope density. Nearly flat correlation for slope density is a correspondence of very close mineral sizes. 
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between the density of the GS, MBF, and slope parameters and the amount of HA added to the 
constructs. These data show a strong linear correlation (R
2
 value of 0.98 and 0.95 respectively) 
between HA content and both the GS and MBF parameters. In contrast, the slope parameter was 
minimally affected by the concentration of HA, as would be expected when the particle size 
remains constant. The linear regression has a slight negative slope (-0.4°), possibly due to 
aggregation of mineral particles at higher concentration. 
3.2.4 Development of collagen constructs in mineralizing media  
The amount of deposition of calcium mineral from the fluid medium on to the collagen 
hydrogel over 3 weeks of time period, as an alternative to incorporating a mineral phase at the 
time of construct fabrication. Three fluid media, PBS (control), 2.5x SBF, 5x SBF were chosen 
to monitor and contrast the mineral deposition on the constructs and the resulting spectral 
ultrasound data at day 21 are shown in Figure 3.7 [1]. The medium was maintained at 37
0 
C and 
at this temperature, the minerals in PBS will be in dissolved state whereas minerals in 2.5x SBF  
 
Figure 3.7 Collagen constructs exposed to mineralizing solution imaged at day 21 of incubation. First 
column shows 3D rendered images, second column shows GS and superimposed MBF, third column 




Figure 3.8 Ai=1to5 shows 3D rendered images of the collagen constructs with mineral deposited by day 3, 
7, 10, 14 and 21 respectively. The left half of Bi=1to5 shows GS image and right half shows MBF image in 
one frame at mineral spotted locations excluding the saturated RF data, if any, at the top or bottom surface 
of the construct. Similar parametric images are shown in Ci=1to5 with right half as spectral slope image. 
and 5x SBF will be in supersaturated state. Within 4 hours, nearly 50% of the calcium ions 
reported [5] to come out of the 5x SBF medium and deposit on the construct. The diameter of the 
spherical precipitates on the construct reported was approximately 12 µm. 
Figure 3.8 [1] shows a temporal analysis of mineral deposition, using the 5X SBF 
constructs as an example because they demonstrated the most robust mineralization. The 3D 




Figure 3.9 Plot of thickness over time of constructs incubated in PBS, 2.5X SBF, or 5X SBF. 
was initiated at the construct surface as early as day 3, and then extended progressively into the 
interior of the construct. Ultrasound imaging also shows the morphology of the construct as a 
whole, and in particular the marked compaction in the z-direction that occurred between day 7 
and day 10. The slope decreased over time, indicating increased particle size, as would be 
expected for a mineral deposition process. 
Thresholding on ultrasound images was used to automatically determine construct 
thickness, by averaging the values in a 5.0 mm × 0.5 mm section. This method takes into account 
changes in construct shape, and therefore can provide an accurate measure of the relevant 
dimensions at any specific location and time. Figure 3.9 [1] shows that constructs in PBS 
compacted 17.4 ± 6.2 % (n = 4, p<0.05) over the first week but recovered over time at days 14 
and 21. Constructs in 2.5X SBF did not compact significantly (1.8±2.8 % at day 7 with p = 0.35) 
over 21 days of incubation and had similar thickness as the constructs in PBS at day 21. 
Constructs in 5X SBF compacted markedly to less than a third of their original thickness (1.75 ± 




Figure 3.10 Calcium density and calculated MBF density over time in constructs incubated in PBS, 2.5X 
SBF, and 5X SBF. 
the remainder of the incubation period. 
The density of the MBF signal over a 0.5 mm x 5.0 mm x thickness volume of each 
construct determined was compared with the extent of mineral deposition as measured by 
calcium content using the OCPC assay. Figure 3.10 [1] shows both MBF density and calcium 
density in constructs over time. Overall, the MBF density matched the measured calcium 
concentration very closely in all constructs (R
2
>0.95 in all cases). In PBS, there was essentially 
no exogenous mineral deposition and the calcium concentration remained below 2 µg/mL. In 
2.5X SBF the calcium content remained low and statistically unchanged over the first 14 days of 
incubation, but then climbed to ~35 µg/mL by day 21, with a corresponding increase in MBF 
density. The 5X SBF constructs were robustly mineralized and the calcium content increased 




Spectral ultrasound imaging rapidly generated objective and quantitative information 
about the morphology and composition of 3D collagen constructs. Importantly, the imaging 
method was noninvasive and could be performed while constructs remained bathed in incubating 
medium. Since the assay was non-destructive, the same samples could be imaged over time to 
monitor their development. In addition, 3D imaging allowed sub-volume analysis and 
comparison of different regions of the imaged constructs through simple processing of the digital 
data. The use of high frequency ultrasound imaging (≈50 MHz) provided a spatial resolution of 
approximately 25 µm, which is suitable for characterization of engineered tissue constructs. High 
frequency imaging resulted in a lower penetration depth than other modalities, but still allowed 
characterization of the 2 mm thick engineered constructs used in this study. We imaged volumes 
on the order of 0.5 cm
3
, but larger volumes can easily be imaged by increasing the lateral scan 
dimension. Importantly, the wide bandwidth available at higher frequencies is beneficial for 
spectral analysis because it provides richer information about the composition of the constructs, 
relative to conventional gray scale imaging. Taken together, these features make ultrasound 
imaging very attractive for biomaterials and tissue engineering research, and potentially for 
quality assurance purposes as engineered tissues approach the market.  
  In this study, we focused on mineral-containing materials because of our interest in 
developing mineralized orthopaedic tissues [6, 7]. Analysis of 3D collagen gels supplemented 
with different types of hydroxyapatite showed that spectral ultrasound can characterize the 
concentration, degree of dispersion, and spatial location of the mineral phase in 3D. In particular, 
3D ultrasound imaging showed clearly the ability of sonication to enhance dispersion of the 
larger HA-R particles as well as the much smaller HA-M and HA-N particles. Mineral 
distribution was best analyzed using the GS and MBF parameters, since both depend primarily 
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on the concentration of scatterers in the sample. The settling and dispersion effects could be 
assessed by color-coding the parametric images, and could be further quantitatively characterized 
using histogram analysis. In addition, the relative concentration of samples supplemented with 
different levels of HA were characterized using ultrasound imaging results, which correlated 
well with the initial loading level. Achieving good dispersion of hydroxyapatite particles 
throughout scaffolds and hydrogels is a well-studied problem in developing biomimetic matrices 
[8], and assessment of dispersion has been a challenge. Our results show that ultrasound imaging 
has the ability to both qualitatively and quantitatively characterize dispersion in 3D samples, and 
can be used to compare treatments designed to enhance dispersion. 
 In the analysis of HA distribution, the GS and MBF data provided similar information. 
However a key distinction between these parameters is that MBF is independent of both the 
imaging system used and the scanning power of the ultrasound probe, whereas the GS data is 
dependent on these factors. Therefore MBF data generated by different users on different 
systems is comparable, whereas GS data is not. This is an important advantage, since the ability 
to generate objective and instrument-independent data makes the method more broadly 
applicable and appropriate for inter-study comparisons.  
 The slope parameter is reflective of particle size. In this study, the slope parameter was 
able to differentiate between HA-R particles (590 µm diameter) and the smaller HA-M (5 µm) 
and HA-N (<200 nm) particles. However the smaller particle sizes could not be differentiated 
from each other because of the resolution of the probe used (approximately 25 µm). While the 
MBF parameter varied with added HA content as the concentration increased, the slope 
parameter remained relatively constant, as would be expected from adding more particles of the 
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same size. The slope parameter is extracted from the RF spectrum and therefore is also 
instrument-independent. 
Simulated body fluid (SBF) was used as way to exogenously mineralize 3D collagen 
matrices, to observe and characterize the evolution of a mineral phase in constructs over time. 
SBF treatment has been developed and validated as a method to deposit a bone-like apatite 
mineral coating throughout scaffolds and hydrogels [9, 10]. Ultrasound imaging revealed the 
pattern, degree and temporal progression of mineral deposition. There was a clear dose-
dependent effect of SBF concentration on mineral development, which was initiated at the 
surface of the constructs. In the most concentrated SBF solution (5X), the formation of a mineral 
“shell” around the construct was followed by a dramatic compaction of the material after a week 
of incubation. Both the mineralization and the compaction processes were tracked over time 
using ultrasound imaging, which are not possible using current histological techniques. The 
spectral parameters were used to quantify the degree of mineral deposition and these results 
correlated well with corresponding data from a destructive calcium quantification assay. The 
reason for the marked volume change in highly mineralized constructs is not clear, but may be 
due to changes in osmotic pressures caused by the mineral shell or the weight of the mineral 
deposits. 
3.4 Conclusions 
 This study showed that high resolution spectral ultrasound can be used to noninvasively 
characterize and monitor 3D protein-based constructs that contain a mineral component. The 
technique provided information about the dimensions and morphology of the construct as a 
whole, as well as the concentration, distribution, and particle size of the mineral phase. 
Furthermore, constructs could be imaged over time to monitor development of a mineral phase 
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and characterize the composition of the matrix. Spectral analysis is particularly useful because it 
generates instrument-independent parameters that can be compared between laboratories, 
studies, and time points. This and similar techniques can generate metrics that reflect material 
and sample properties, and therefore may have utility in advancing research and product 
development in tissue engineering. 
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Monitoring the development of tissue engineered products in a non-destructive method to 
ensure its quality assists the product transition from lab to clinic. In this study, high resolution 
spectral ultrasound imaging (SUSI) was used to identify the differentiation process of MC3T3 
pre-osteoblasts and quantify the calcium mineral deposition in the construct by the differentiated 
cells. 
4.1 Introduction 
Improved imaging modalities in the evaluation of tissue engineered construct is necessary 
to translate the lab product into clinic. Bone tissue engineering approaches combine cells, 
biomaterials, and growth factors to recreate native bone tissue [Langer R, 1993]. Traditionally, 
biochemical and histological assays are performed in order to monitor cell function and 
development in these engineered tissues. However, these techniques require sample processing 
and are destructive in nature. These analysis modalities can only describe general characteristics 
of the sample rather than three dimensional (3D) spatial information. Further, these methods do 
not allow for one individual sample to be tracked as it progresses due to their destructive nature. 
Non-destructive imaging and characterization modalities, such as high-resolution ultrasound, 
50 
 
could aid in the translation of engineered tissues towards clinical use if they could provide spatial 
and temporal information of constructs as they develop in vitro.  
Although non-destructive approach based on confocal microscopic imaging to count cell 
nuclei has been used to provide 3D assessment of cells [1], such techniques require high quality 
microscopy images, and are time consuming involving sophisticated procedures to acquire the 
entire spatially registered 3D microscopy images of the construct. Magnetic resonance imaging 
(MRI) and micro-computed tomography (µ-CT) techniques have been used to estimate bone 
mineral densities [2, 3]. However, these methods require usage of calibration phantoms and long 
data acquisition times [4]. Long exposures to X-ray may affect the cell-seeded constructs in 
terms of the nature, viability, and cellular development of the constructs. Conventional MRI 
imaging systems do not provide the ability to study the microstructural details of the constructs 
due to their low resolution. Even with these limitations, non-destructive imaging and 
characterization modalities are capable of providing both spatial and temporal information of 
engineered tissue constructs as they develop in vitro and could greatly facilitate the translation of 
these products from lab to clinic. 
Ultrasound imaging is a well-known non-invasive and non-destructive method, which 
may provide a potential means for quantitative evaluation of tissue development both in vitro and 
in vivo.  It has been reported recently that ultrasound can be used to quantify the number of cells 
in BMSC/β-TCP composites using a grayscale equivalent parameter [5]. Fite et al. utilized an 
ultrasound method to monitor the chondrogenic differentiation of equine adipose stem cells in 
3D poly(lactide-co-glycolide) scaffolds [6] by correlating signal attenuation measured through 
gray scale image analysis to extracellular matrix (ECM) deposition, which was considered to be 
a marker of cell differentiation. Kreitz et al. tracked collagen deposition by myofibroblasts in 
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fibrin tissue constructs over an 18 day culture period [7]. Their quantitative analysis of observed 
gray scale values were correlated to ECM deposition as measured by hydroxyproline content. 
Ultrasound has also been used as a tool to measure the mechanical properties of agarose 
hydrogels as they develop over time [8]. The authors correlated material properties such as 
elastic modulus with obtained acoustic properties.  
Since ultrasound propagation and acoustic scattering in tissue volume depend upon tissue 
microstructure, composition, and physical properties such as density and compressibility, the 
backscattered ultrasound signals may be used to extract information of the structure and 
composition of the tissue under investigation, as well as its mechanical and physical properties. 
Although tissue properties such as speed of sound, acoustic attenuation and the tissue volume 
can be calculated directly from the backscattered radiofrequency (RF) data, tissue 
microstructural details are not apparent from the raw RF signals. Tunis et al. [9] studied the 
envelope statistics of ultrasound backscatter signals from cisplatin-treated aggregated acute 
myeloid leukemia (AML) cells and evaluated the applicability of various statistical distribution 
functions to model the envelope histograms. They reported that shape parameters of the 
generalized gamma distribution function were sensitive to the structural changes within cells 
induced by the drug.  
Quantitative ultrasound imaging methods using spectral analysis of the RF signals have 
been developed to extract such information for tissue characterization. The power spectrum of 
the tissue backscattered RF data includes information of tissue microstructure and the spectral 
regression parameters are used to relate to scatterer properties such as effective sizes, 
concentrations and acoustic impedances of tissue scatterers [10, 11]. Spectral slope was shown to 
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depend upon the scatterer size whereas mid-band fit (MBF) depend on size, concentration and 
relative acoustic impedances of scattering elements [10].  
The technique of spectral analysis has been used in various applications, including 
characterization of plaque composition by intravascular ultrasound (IVUS) [12, 13], lesions 
induced by high intensity focused ultrasound (HIFU) [14, 15] and RF ablation [16]. Spectral 
parameters have also proven to identify changes in tissue state for prostate, breast, pancreas, 
lymph nodes, and other cancer tissues [17-23]. Oelze et al. [18] also developed method to 
differentiate and characterize rat mammary fibroadenomas and 4T1 mouse carcinomas by 
estimating scatterer properties from backscatter RF signals in the spectral domain with a 
Gaussian form factor model [24]. 
In particular, the use of high frequency (20 – 60 MHz) ultrasound imaging has provided 
high spatial resolution than conventional ultrasound imaging (5 – 15 MHz) in diagnostic 
radiology [19]. Kolios et al. have shown spectral analysis technique to analyze the properties of 
cell ensembles or aggregates, which were used as simplified models of tumors [19, 25], to detect 
cellular changes with high spatial resolution and sensitivity due to exposure to chemotherapy 
drug treatments [26]. They found that ultrasound backscatter intensity and spectral slope 
increased because of treatment and that was interpreted as a consequence of the decrease in 
effective scatterer size of cell aggregates, Here the higher ultrasound frequency imaging, with 
corresponding ultrasound wavelengths in the order of 100 μm, permitted sensing of changes in 
cell nuclei and cell structure.  
Thus, to provide non-invasive and quantitative assessment of engineered tissue constructs 
with high spatial resolution, we have implemented a spectral ultrasound imaging (SUSI) 
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technique to characterize composition and structure characteristics of tissue engineered 
constructs. Recently we have utilized the spectral MBF and slope parameters to characterize the 
quantity and spatial distribution of particulate hydroxyapatite in acellular collagen hydrogels 
[27]. We observed a strong correlation between MBF and mineral concentration and between the 
slope and particle size. The amount of mineral deposited from the simulated body fluid on the 
acellular collagen constructs over development period of 3 weeks was also studied using spectral 
parameters and showed strong correlation with MBF.  
The current work extended our initial results using high resolution SUSI to study the 
osteogenic differentiation of MC3T3 mouse pre-osteoblast cells seeded within collagen 
hydrogels. MC3T3 cells are a well characterized mineralizing cell type that can be induced 
towards the osteogenic lineage with the addition of pre-determined chemicals in the culture 
media [28]. Collagen is a widely used biomaterial due to its ability to support cell attachment and 
proliferation as well as serve as an osteoconductive and osteoinductive material [29]. Bulk 
properties such as speed of sound, acoustic attenuation and volume compaction of the constructs 
were quantified and tracked over time. Microstructural properties such as cell size, cell number, 
and cell differentiation of the MC3T3 seeded constructs were characterized using spectral 
ultrasound and are compared to traditional biochemical assays and confocal images. The results 
from this study are in the process of submission to a journal with the title, “Non-invasive 
Quantification of In-vitro Osteoblastic Differentiation in 3D Engineered Tissue Constructs using 
Spectral Ultrasound Imaging”.  
4.2 Materials and Methods 
 The tissue constructs were manufactured in Cell-Matrix Interactions & Tissue 
Engineering (CMITE) lab, Department of Biomedical Engineering. 
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4.2.1 Cell Culture 
Mouse pre-osteoblast MC3T3-E1 were cultured in α-MEM without ascorbic acid (Life 
Technologies, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS; Life 
Technologies) and 1% penicillin and streptomycin (PS: Life Technologies) and used at passage 
8. Media was changed every other day. 
4.2.2 Collagen Hydrogel Synthesis 
 Three-dimensional (3D) collagen hydrogels were created as previously described [Gudur 
MS, 2012]. Collagen type I (MP Biomedicals, Solon, OH) was prepared at 4.0 mg/ml in 0.02 N 
acetic acid. Collagen hydrogels (2.0 mg/ml final concentration) were formed by mixing 10% 
Dulbecco’s modified Eagle’s medium (DMEM; Life Technologies), 10% FBS, 20% 5X-
concentrated DMEM, 10% 0.1 N NaOH (Sigma Aldrich, St. Louis, MO), and 50% collagen 
stock solution.  500 μL of the mixture was then pipetted into a 24-well plate and allowed to gel 
for 30 mins at 37°C. Cells were encapsulated within the hydrogels at the time of gelation at a 
concentration of 1.0 x 10
6
 cells/ml.   
After gelation, hydrogels were placed in a 6-well culture plate containing α-MEM 
supplemented with 10% FBS and 1% PS. After 24 hours, the media was changed with either a 
control media or osteogenic media containing 10 μM beta-glycero phosphate (-GP; Sigma) and 
5 μg/ml ascorbic acid (Sigma).  
4.2.3 Cell Viability 
 Cell viability was visualized and quantified as previously described [Rao RR, 2012]. At 
days 1 and 21, cell-seeded hydrogels were washed 3X in phosphate buffered saline (PBS; Life 
Technologies) for 5 mins and then incubated in 4 μM calcein-AM (EMD Millipore, Billerica, 
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MA) and 4 μM ethidium homodimer-1 (Sigma) in PBS for 45 mins. Constructs were washed 3X 
in PBS prior to imaging on a Nikon A1 Confocal Microscope (Nikon Instruments, Melville, 
NY). Cell viability was quantified using ImageJ software (National Institute of Health, Bethesda, 
MD).  
4.2.4 Fluorescence Staining 
 At days 1 and 21, cells were stained for their actin cytoskeleton and nuclei. Hydrogels 
were washed 2X in PBS for 5 mins/wash and then fixed in zinc-buffered formalin (Z-Fix; Battle 
Creek, MI) for 10 mins at 4°C. Gels were washed another 2X in PBS and then permeabilized 
using 0.5% Triton-X 100 (Sigma) in PBS for 20 mins at room temperature. Constructs were 
washed again 2X, and then incubated in a solution containing 165 nM AlexaFluor 488 phalloidin 
(Life Technologies) and 10 nM fluorescent DAPI (Life Technologies) in 1% bovine serum 
albumin (BSA; Sigma) in PBS for 45 mins. Hydrogels were washed again prior to imaging.  
4.2.5 Biochemical Assays 
 Cellular DNA content and calcium were quantified as previously described [Rao RR, 
2013]. For DNA quantification, hydrogels were collected and degraded overnight in 10 mM 
Tris-HCl (Sigma) containing 0.6 mg/mL collagenase type I (MP Biomedicals), 0.2% IGEPAL 
(Sigma), and 2 mM phenylmethanesulfonylfluoride (Sigma). DNA was then measured using the 
PicoGreen DNA assay (Life Technologies). Calcium secretion from the cells was assays using an 
ortho-cresolphthalein (OCPC) method on the lysate. 
4.2.6 Ultrasound Imaging and Backscattered Signal Acquisition 
  Figure 4.1 shows a schematic diagram of the imaging setup that includes a 60 mm 
diameter Petri dish lined with 8% agarose (Lonza) at the bottom to reduce the ultrasound 
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reflection from the bottom of the dish. The dish was then filled with α-MEM at room 
temperature and the constructs were placed on top of the agarose gel pad. Ultrasound imaging 
was performed with a Vevo 770 (VisualSonics Inc., Toronto, Canada) using an RMV 708 
imaging probe with a nominal 55 MHz center frequency, 20-75 MHz bandwidth (−6 dB), 4.5 
mm focal distance, and 1.5 mm depth of focus (−6 dB). For the tissue construct composition 
estimation, 3D backscattered RF data with ultrasound focus on the tissue construct were 
collected at 100% scanner power for cell differentiation study and 50% or 100% for cell 
concentration study at 420 MS/s sampling rate by performing multiple B-mode scans using an 
automatic 3D translational controller. The interval between adjacent A-lines and B-mode scans 
were 31 μm and 200 μm, respectively. For estimating the speed of sound and acoustic 
attenuation of the construct, 2D backscattered RF data with ultrasound focus at the gel pad 
surface were collected at 20% scanner power along with a reference RF acquisition of the setup 
without the construct. Apart from the RF data, 3D image data with separation between adjacent 
A-lines and B-mode scans of 31 μm and 100 μm respectively, was also collected to visualize 3D 
rendered images and to estimate the volume of the construct. 
 




4.2.7 Ultrasound Backscattered Signal Analysis 
4.2.7.1 Volume: Volume of the construct was estimated by a semi-automated segmentation 
procedure on Vevo 770 system, in which an edge detection algorithm detects the contour of the 
construct in a frame. Subsequent contours in adjacent frames are drawn semi-automatically until 
the contours in all frames are drawn, thus calculating the volume of the gel within the contoured 
region. 
4.2.7.2 Speed of Sound: Grayscale parameter [27] is computed from 2D RF data. The time of 
travel of the ultrasound pulse to the construct’s top surface  to pt , bottom surface  b o tto mt and to 
the agar gel pad  
c o n s tr u c t
p a d
t was determined based on grayscale thresholding using an automated 
algorithm. The time of travel to the agar gel pad without the construct  
r e f
p a d
t  was also determined 
as the reference. Using the known sound speed in the surrounding fluid medium  fC , the 
thickness of the construct (L) and speed of sound in the tissue construct  tcC was determined as: 
    0 .5
re f c o n s tru c t
f b o tto m to p p a d p a d


























   (4.3) 
where |A(f)| and |A0(f)| are the spectral magnitudes of RF signal at the gel pad surface with and 
without (reference) the construct respectively. The slope of α against f estimated by a linear fit 
between 20-55 MHz provides attenuation in dB/(cm-MHz).                                         
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4.2.8 SUSI Analysis 
4.2.8.1 Scatterer Size and Concentration: By the method described in Chapter 2 on estimating 
the scatterer size and concentration from the spectral parameters, MC3t3 cell size and cell 
concentration are estimated at various time points of cell development. To estimate concentration 
for samples until day 14, when there is no calcium deposition, a relative acoustic impedance, Q, 
value for MC3t3 cells was used from the Q value obtained from MC3t3 cell concentration study. 
4.2.8.2 Cell deposited calcium: MC3T3 differentiation process can be identified by detecting 
and quantifying the mass of the calcium deposited in the construct by the differentiated MC3T3 
cells. On day 21, the presence of deposited calcium around the cell will increase relative acoustic 
impedance of the net scatterer. With known relative acoustic impedance of the scatterer on day 
14 (cell alone) and day 21 (cell and calcium), mass of the calcium can be calculated. The relative 
acoustic impedance is 








  (4.4) 
where ρ and ρ0 are the densities of the scatterer and ECM, c and c0 are the speed of sound in the 
scatterer and ECM respectively. Solving for the total mass of calcium (derivation shown in 
Appendix) 
   
0 0
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   (4.5) 
where V14 is the  volume of the scatterer on day 14 and is approximately 
 
 
    
4.2.9 Parametric Images  
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 The spatial distribution of scatterer features of the construct on the GS B-mode images 
were represented by marking each pixel within the construct with a color that corresponds to the 
values of the scatterer size and concentration. 
4.2.10 Statistical Analysis 
 Analysis was carried out on a 0.6 mm x 5.0 mm x thickness (~1 mm) volume of each 
construct and the data are presented as mean ± standard deviation. Statistical comparisons 
between any two parameters were made using Student’s t-test for paired samples and the 
differences were considered significant at a level of p<0.05. 
4.3 Results 
4.3.1 MC3t3 Relative Acoustic Impedance 
 To estimate the number concentration, C, of the scatterers from SUSI analysis, their 
relative acoustic impedance needs to be determined. An experiment with MC3t3 cell constructs 
at four different known concentrations, 0.5, 1, 2 and 5x10
6
 cells/ml on day 0 was carried out to 
perform SUSI analysis and estimate cell diameter and cell acoustic concentration. The ultrasound 
B-mode images of these constructs are shown in Figure 4.2A-D. Constructs with known 
concentration of cells at 2x10
6
 cells/ml was used to estimate the relative acoustic impedance of 
the MC3T3 cells from SUSI analysis. Then the estimated relative acoustic impedance was used 
to estimate the cell concentration of cells in the other constructs with different cell concentration 
(0.5, 1 and 5x10
6
 cells/ml) at day 0. Using SUSI analysis, the estimated cell diameter was 
approximately 14 ± 1.5 µm (n = 9) and decreased slightly with increased cell concentration 
(Figure 4.2E), likely due to compacting of the constructs with higher cell concentration. The 




Figure 4.2 (A)-(D) Ultrasound B-mode images of MC3t3 cell constructs on Day 0 at 0.5, 1, 2 and 5 x10
6
 
cells/ml cell concentrations respectively. (E) Cell diameter and (F) Cell concentration estimated from 
SUSI analysis w.r.t true cell concentration (G) Tabular values of true and estimated cell concentrations. 
estimated concentration against the true concentration (R
2
 = 0.92) (Figure 4.2F) confirm the 
ability of SUSI for detecting cell concentration.  With the estimated relative acoustic impedance 
of the MC3t3 constructs, estimation of MC3t3 cell concentration to assess the process of cell 
proliferation/apoptosis and cell differentiation will be feasible. 
4.3.2 Ultrasound Histology 
Imaging using the Vevo 770 system at 55 MHz achieved rapid and non-invasive 3D 
ultrasound imaging of MC3T3 collagen constructs. During ultrasound imaging, the constructs in 
α–MEM media were outside of the incubator for less than 20 minutes. The 3D rendered 
ultrasound images and the brighfield images of the constructs in control and osteogenic media at 
time-points day 1, 7, 14 and 21 are shown in Figure 4.3. It clearly show that the constructs in 
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both control and osteogenic media adopt a symmetrical bowl-like shape from day 1, which could 
be due to the meniscus formation during preparation of the gels. Compaction of the constructs 
was evident for both constructs in control and osteogenic medium. In addition, the constructs in 
osteogenic medium became more echogenic than those in control medium, indicating changes 
occurring during development in osteogenic medium. The constructs in both control and 
osteogenic media has drop in volumes over time, which is quantitatively measured and shown in 
Figure 4.4A. There is no significant difference between the drop in volumes between control and  
 
Figure 4.3 3D rendered ultrasound backscattered images of MC3t3 cell constructs in control (1
st
 column) 
and osteogenic media (2
nd
 column) on day 1, 7, 14 and 21 of the development process. Brightfield images 







osteogenic media at any specific time-point, an indicator of growth media independent process. 
From day 1, drop in volume on day 7 is statistically significant and the drop is significant there 
onwards. Acoustic parameters such as speed of sound and acoustic attenuation were also 
estimated and shown in Figure 4.4B and 4.4C respectively. There is a gradual insignificant 
increase in speed of sound over development time for constructs in both control and osteogenic 
media. Attenuation increased almost linearly over development time with increase in attenuation 
for construct in osteogenic media on day 21 slightly more than for the construct in control media 
on day 21, the increase being statistically insignificant. Attenuation estimation will be used to 
compensate for the construct attenuation in estimating the correct spectral parameters. Volume 
and speed of sound will be used to determine the amount of calcium deposited by the 
differentiated cell constructs in osteogenic media. 
4.3.3 Cell Viability 
Cell viability in the constructs with and without ultrasound imaging was compared to assess 
possible effects of ultrasound imaging As shown in Figure 4.5, viability was greater than 90% at 
day 1 in all of the samples and greater than 70% in all samples at day 21, and there were no 
statistical differences between the samples with and without ultrasound imaging at either time 
point, indicating that exposure to ultrasound imaging did not affect cell viability. 
4.3.4 Changes in Volume, Sound Speed and Acoustic Attenuation 
As shown in Figure 4.5A, a significant decrease in construct volume between days 1 and 
7 was observed before the construct volume remained constant between days 7 through 21. No 
significant difference in the volumes was detected between control and osteogenic media at any 




Figure 4.4 Cell viability assay on day 1 and 21 of MC3t3 constructs in control and osteogenic media. 
Constructs on the left half were not imaged using ultrasound in contrast to the right half. Bottom bar plot 
shows the percentage of cell viability calculated from the images. 
constructs in both control and osteogenic media. The most significant change is the acoustic 
attenuation, which increased almost linearly over development time with no significant 
difference between constructs in control and osteogenic media. Since the acoustic attenuation is 
typically an indicator of increased acoustic impedance and/or scatterer concentration, this 




Figure 4.5 (A) Volume (B) Speed of Sound and (C) Attenuation of the MC3t3 constructs in control and 
osteogenic media at various time-points. 
These results of construct volume, speed of sound, and acoustic attenuation were used in 
further analysis of the constructs including estimation of spectral parameters and calcium 
deposits by the differentiated cell constructs in osteogenic media. 
4.3.5 Diameter 
Figure 4.6A-4.6D shows the seeded MC3T3 cells in the collagen hydrogels with the F-
actin filaments stained in green and cell nuclei stained in blue at 40x microscopic view. From 
these images, diameters of the cell nuclei were estimated using a customized MATLAB script to 




Figure 4.6 (A)-(D) Immunofluorescence staining of MC3t3 constructs in control and osteogenic media on 
day 1 and day 21. (E) Estimated diameter of the cell from SUSI analysis during the development time. 
statistically insignificant. The effective sizes of the cells over the three week period were also 
estimated using the slope parameter obtained from SUSI analysis (Figure 4.6E). The average 
diameter for the cells, 14 ± 1.5 µm (n = 9) remained essentially unchanged during the three week 
period for constructs in both control and osteogenic media, suggesting that the cells were 
involved in the scattering of ultrasound, not merely cell nucleus. 
4.3.6 Acoustic Concentration and Calcium Deposit in Constructs 
The total amount of DNAs in a construct was measured and converted to the total number 
of cells by calibrating with the amount of DNAs in the construct on day 0 when the number of 
cells was known (0.5x10
6
/construct). As shown in Figure 4.7A, the number of cells decreased by 
about 60% from day 1 to day 7 in constructs in both the control and osteogenic groups, 
indicating cell death during this period, although the number of cells remained constant from 
days 7 to 21 with no significant differences in either media groups. These numbers of cells 





) estimated by SUSI analysis multiplied by the construct volume, except that 
on day 21 in the osteogenic group (Figure 4.7B). The acoustic concentration from SUSI depends 
on both the relative acoustic impedance of the scatterers (Q) and the actual number of scatterers 
(C). Thus assuming the actual number of scatterers or cells remained constant, the increased 
equivalent number of acoustic scatterers (or increased acoustic concentration) can be attributed 
to an increase of the relative acoustic impedance of the scatterers during the last days of 
incubation of the constructs (Figure 4.7C). The significantly increased acoustic impedance on 
day 21 indicates the changes due to the differentiation process in the constructs. Since acoustic 
 
Figure 4.7 Total number of cells derived from the DNA quantification of MC3T3-seeded collagen 
constructs in control and osteogenic media during the development time. (B) Total number of acoustic 




Figure 4.8 (A) Calcium content from OCPC method and SUSI estimate (B) Calcium assay on MC3T3-
seeded collagen constructs in control and osteogenic media with and without exposure to ultrasound 
imaging. 
impedance depends on mass density and speed of sound of scatterers, the increased acoustic 
impedance implies possibly an increase of mass density due to calcium deposits associated with 
the cell differentiation. As calcium is much denser than water, its presence is expected to 
significantly increase the relative acoustic impedance of the scatterers.  
As a quantitative marker to identify the extent of osteogenic differentiation of seeded 
MC3T3 cells [30], we estimated the calcium content using standard assays (OCPC method) and 
SUSI. The estimated calcium concentration from SUSI on day 21 was 41.7 ± 11.4 µg/ml (n = 9) 
and was comparable with the measured values of 38.7 ± 16.7 µg/ml (n = 10) from OCPC 
method. No statistically significant difference in the calcium deposition at day 21 was detected in 
constructs subjected to ultrasound imaging and those without ultrasound imaging performed 
(Figure 4.8B). 




Figure 4.9 Scatterer feature estimates, diameter (left half) and calcium concentration (right half) of 
MC3t3 constructs in control and osteogenic media. 
The estimated microstructural properties (acoustic scatterer size and secreted calcium 
concentration) from SUSI analysis were used to form parametric images or color coded images 
overlaid on B-mode images to assess the spatiotemporal evolution of constructs during 
development. As an example, Figure 4.9 shows the estimated microstructural parameters in a 
representative region of interest for constructs in control and osterogenic groups throughout the 
development duration. The scatterer diameter was uniform within the construct, and did not vary 
during the development process for constructs in either control or osteogenic medium (Figure 
4.9A). The estimated calcium concentration was fairly constant at low values at all time-points, 
except for the constructs in osteogentic medium on day 21 that exhibited a significantly higher 
value, indicating the result of osteogenic differentiation of MC3T3 cells in the constructs. 
4.4 Discussion 
In this study, we demonstrated that high resolution ultrasound imaging provided non-
destructive monitoring of the MC3T3-seeded collagen constructs over 3 weeks. Physical 
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parameters including the volume of each individual construct, speed of sound and acoustic 
attenuation in the constructs were obtained from simple analysis of the ultrasound imaging 
signals. Notably, beyond analyses that based on conventional ultrasound images, SUSI analysis 
provided estimation and assessment of the microstructural characteristics of the constructs, 
including the cell size, acoustic concentration, changes in number of cells and mineral secretion. 
Since system factors are removed from SUSI analysis by calibration, the SUSI parameters 
provide objective and instrument-independent analysis which can be more broadly applicable 
and appropriate for inter-study comparisons. These features make ultrasound imaging and 
particularly SUSI a very attractive tool for biomaterials and tissue engineering research, as a 
potential means for use in quality assurance as engineered tissues approach the market. Below 
we discuss implications of our results and limitation of this study. 
4.4.1 Morphological Changes in Tissue Constructs 
Cells such as fibroblasts, smooth muscle cells, cardio myocytes or osteoblasts placed 
within a collagen matrix remodel the matrix by exerting substantial contractile forces [31]. These 
forces are significantly higher than the forces required to propel cell locomotion and it has been 
proposed that their main function is morphing the structure of the construct rather than to drive 
cell migration [32, 33]. Assessment of tissue construct morphology in 3D in a non-invasive 
method is important to study these changes. In this study, we showed that high resolution 3D 
ultrasound imaging readily identified the morphological behaviors of tissue constructs 
longitudinally, revealing the significant compaction of the MC3T3 constructs from day 1 to day 
7 since the constructs were unconstrained in the culture plate. 
4.4.2 SUSI Quantification of Microstructural Changes in Tissue Constructs 
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We showed that ultrasound imaging provides non-destructive monitoring without 
affecting the nature of the constructs. In this study, SUSI analysis revealed that the total number 
of cells in the unconstrained MC3T3-seeded collagen constructs decreased by approximately 
80% throughout the 21 day time period. It is possible that the decrease in cell number was due to 
the decrease in construct volume. A similar cell death pattern was observed in a previous study 
of unconstrained constructs seeded with undifferentiated mesenchymal stem cells (MSC) [34]. 
The acoustic concentration, or CQ
2
, where C is the number concentration of the scatterers 
and Q the acoustic impedance of the scatterers, depends on the scatterer physical and acoustic 
properties such as the mass density and speed of sound. Thus assessment of the total number of 
acoustic scatterers (CQ
2
 multiplied by construct volume) can provide information regarding the 
changes associated with MC3T3 cells differentiation towards the osteogenic lineage. As the cells 
secrete mineral into the surrounding ECM [30] to modify the properties of the acoustic 
scatterers, most likely by increasing the mass density of the scatterers and thus its relative 
acoustic impedance. Hence, relative acoustic impedance can be used as an indicator of changes 
in cellular state during osteogenic differentiation. In the current study, we not only qualitatively 
identified the differentiation process via changes in the relative acoustic impedance, but also 
obtained quantitative values of the mass of calcium based on the relative acoustic impedance 
values with minor assumptions in the model. To our knowledge, this is the first study to propose 
an ultrasound imaging-based method to estimate the mass of calcium mineral in collagen 
constructs as MC3T3 cells differentiate in osteogenic medium. 
4.4.3 Limitations 
The current study demonstrated the advantages of high frequency ultrasound imaging for 
monitoring of tissue construct development. The higher frequency used here ensured high spatial 
71 
 
resolution, which might not be fully translatable to clinical settings where lower frequency (e.g. 
10 MHz) imaging is typically used for deep tissue penetration as higher frequency ultrasound 
suffers from higher attenuation in tissue.  
Our estimation of the relative acoustic impedance in this study required knowledge of the 
number of cells, which may not be readily available non-destructively. Otherwise, a composite 
parameter, the acoustic concentration (CQ
2
), which is obtained directly from SUSI analysis, can 
be used to assess the changes in the constructs. However, this would prevent quantitative 
estimation of mass of calcium in the constructs specifically. In addition, we assumed that 
calcium deposited by the cells was not separated from the cells to be regarded as different 
scatterers from the cells. Future investigation on different cell types/conditions will provide 
additional validation of the proposed technique. 
4.5 Conclusions 
In this study, high resolution spectral ultrasound imaging (SUSI) was used to identify the 
differentiation process of MC3T3 pre-osteoblasts and quantify the calcium mineral deposition in 
the construct by the differentiated cells. Cell size and concentration were estimated from SUSI to 
study the construct development in maintenance and osteogenic media. Volume compaction of 
the constructs, cell proliferation, and cell differentiation measured by calcium secretion were 
identified and distinguished between constructs in both media. Estimated cell diameter was 13 
µm and the variation was negligible during the development process. Cell proliferation/apoptosis 
and nucleus size were verified by biochemical assays. The amount of calcium secreted by 
differentiated cells into the construct estimated using SUSI analysis was 41.7±18.1 µg/ml, 
matching closely with OCPC method for calcium values of 38.7±16.7 µg/ml. These data 
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demonstrate that cell differentiation process can be quantitatively identified using non-invasive 
SUSI and that these techniques will assist the development of orthopedic engineered tissues. 
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High intensity focused ultrasound (HIFU) technology holds potential for clinical ablation 
therapy [1-3] due to its ability to noninvasively generate necrosis in targeted tissue volumes with 
minimal effects on surrounding and intervening tissue. The formation and extent of HIFU-
induced tissue necrosis, or thermal lesion, is determined by the spatiotemporal distribution of 
temperature-increase induced by HIFU exposure [4, 5].To achieve better control of the ablation 
process, robust and effective imaging methods are needed for real-time monitoring of tissue 
changes such as lesion formation during HIFU application. Magnetic resonance imaging (MRI) 
has been valuable in guiding and monitoring HIFU ablations [6-8] in real-time with spatial and 
temporal control on temperature rise in the tissue induced by HIFU. While magnetic resonance 
imaging (MRI) [6] and x-ray computed tomography (CT) [9] have been used as effective image 
guidance during ablation, monitoring with diagnostic ultrasound imaging has the advantage of 
relatively lower cost, higher portability, and high spatiotemporal resolution. Although a variety 
of methods have been proposed to improve ultrasound imaging of HIFU ablation and lesion 




The tissue changes generated by HIFU application include changes in the acoustical 
properties such as sound speed, attenuation, and ultrasound backscatter due to protein 
denaturation, coagulation, gas-body formation, and other effects. While a variety of methods like 
temperature changes by tracking echo shifts [10], changes in ultrasound backscatter [11-13], 
elastographic imaging [14-17], attenuation changes [18-20], spectral analysis [21], echo 
decorrelation [22] have been proposed to improve ultrasound imaging of HIFU ablation and 
lesion formation based on these changes, ultrasound imaging has not yet been established as a 
robust and consistent technique. 
Occurrence of gas bodies is another event that often forms during HIFU ablation due to 
cavitation, tissue degassing, and/or boiling [23]. These gas bodies strongly scatter ultrasound and 
distort the HIFU beam, resulting in inefficient ablation of distal tissue segment [24] and altered 
lesion location, shape and size from the original treatment plan. The presence of gas bodies can 
also result in enhanced heating beyond thermoviscous absorption [25]. In some cases, due to the 
combined effect of high acoustic pressure and rapid heating, macroscopic cavities may be 
generated in tissue during ablation. The stochastic nature of these events causes variation in 
outcomes that are not well controlled. Thus it is important to detect these events and develop 
strategies to prevent them. To detect these gas bodies, various passive [26-29] and active 
cavitation detection strategies [28, 30-32] have been proposed including methods for spatial 
cavitation mapping [33-35] to locate these gas bodies, but no clear strategies have been 
developed to predict the capability of gas bodies in creating macroscopic cavity in the tissue. 
In this study, we focus on developing methods of high frequency, high frame rate B-
mode ultrasound imaging to monitor formation of lesion and gas bodies during HIFU ablation 
using ex vivo cardiac tissue specimens, aiming to improvise the monitoring method in HIFU 
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treatment of atrial fibrillation. B-mode RF data were acquired and are analyzed using grayscale, 
integrated backscatter, calibrated spectral parameters, echo decorrelation to obtain time-evolving 
HIFU-monitoring parameters. By comparing against gross images, the best method(s) for lesion 
identification are assessed via receiver-operating characteristic (ROC) curves [36]. For gas-body 
identification, a frame-to-frame echo decorrelation method [22] is proposed to evaluate the 
dynamic local motion and the expansion rate of the gas bodies and to predict the formation of 
cavities during ablation. The results from this study were submitted to IEEE Transactions on 
UFFC, volume 59, issue 8, 2012 with the title, “High-frequency rapid B-mode ultrasound 
imaging for real-time monitoring of lesion formation and gas body activity during high-intensity 
focused ultrasound ablation”  [37]. 
5.2 Methods 
The experimental setup, shown in Figure 5.1(a) [37], consists of a HIFU system and a 
high frequency ultrasound imaging system (Vevo 770, VisualSonics, Toronto, Canada). In a 
water tank, the HIFU transducer and a Vevo imaging probe (RMV 708, nominal 55 MHz center 
freq., 20-75 MHz bandwidth [−6 dB], 4.5 mm focal distance, 1.5 mm depth of focus [−6 dB]) 
were perpendicularly and confocally aligned with the common focus placed within ex vivo 
porcine cardiac tissue. The HIFU system consisted of a signal generator, power amplifier, and 
spherically focused HIFU transducer (4.33 MHz center frequency, 40 mm diameter, 42 mm focal 
distance) and was used to generate pulsed exposures with 2600 W/cm
2
 focal intensity and 
various PRF’s (77 Hz, 103 Hz, 130 Hz), duty cycles (25%, 50%) and exposure times (0.2 s, 
0.6 s, 1 s). The STBM imaging was synchronized with the HIFU pulses to image during the off-
duration of the HIFU pulses to avoid interference (Figure 5.1(b)), thus the frame rate of STBM 
imaging was the PRF of the pulsed HIFU exposure. 
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To achieve a high frame rate of imaging, short-time B-mode (STBM) imaging (B-mode imaging 
with a reduced window size of dimensions 0.8 mm x 11 mm) was employed. Backscattered RF 
data of STBM imaging were acquired before, during and after HIFU application. After the 
experiment, the tissue was cut transversely through the lesion and photographs of the lesion 
cross-section were taken. 
 
Figure 5.1 (A) Experimental setup of image-guided HIFU system (not to scale) (B) Sequence of HIFU 
and RF synchronized pulses. 
5.2.1 Feature Estimation Parameters: The following estimation parameters were computed 
from the acquired RF data: 
5.2.1.1 Grayscale (GS): The A-line signal acquired in STBM data was Hilbert transformed to 
obtain the complex analytic signal p(y,z,t). The grayscale parameter in decibels (dB) of a 
spatially smoothed frame at time t is calculated as 
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  1 0( , , ) lo g ( , , )G S y z t p y z t , (5.1) 
where the spatial smoothing with window w(y,z) was defined by  
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was used as the smoothing window represented in Eq. (2) with the length scale γ as 14 µm. 
5.2.1.2 Integrated Backscatter (IBS): The auto-correlation function of a frame at time t is 
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where R0(y,z,0) is the temporal average of autocorrelation of the frames before HIFU ablation 
treatment.  
5.2.1.3 Frame-to-Frame Decorrelation: A spatiotemporal correlation function between two 
successive frames with a time delay τ [22] is      , , , , , , ,R y z t p y z t p y z t 

  . The 
normalized frame-to-frame decorrelation parameter similar to the variance of the spectrum in 
“flow turbulence” denoted by Kasai et al. [38], is then defined as 
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where  0R t is the spatial mean of R0(y,z,t) for the frame obtained at time t.  
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5.2.1.4 Initial Frame Decorrelation: The initial frame decorrelation is defined as the 
decorrelation between any frame at time t and a frame at t = 0 (initial frame): 
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5.2.1.5 Spectral Parameters: The power spectrum of the STBM data was calculated for the 
signals of each RF A-scan within the ROI by taking the Fast Fourier Transform (FFT) of the data 
gated by a series of sliding Hamming windows of 0.2 μs, each offset by 0.1 μs. The calibrated 
power spectra were characterized by linear regression to find the spectral parameters, i.e. the 
midband-fit ( , , )M y z t , which is the value of the linear function evaluated at the midpoint of the 
−15 dB bandwidth, the slope ( , , )m y z t , and the intercept ( , , )I y z t . The relative change in the 
spectral parameters were computed to minimize the effects of variability in the initial state of the 
specimens, e.g., for midband fit, 
0
( , , ) ( , , ) ( , )M y z t M y z t M y z   , where 
0
( , )M y z  is the 
temporal average value of the spectral parameter in the frames prior to application of HIFU. 
5.2.2 Lesion mask and lesion identification: To construct ROC curves between the post-HIFU 
frame of STBM data and the gross image, a binary mask for the lesion in gross image at the 
STBM window location was identified. The proposed parameters defined in A.1-A.5 are 
evaluated on each frame of STBM data. For any given parameter X(y, z, t) defined in A.1-A.5, the 
temporal maximum of the parameter was also computed according to  
     m ax 0 0, , m ax , , 0
t
X y z t X y z t t   . (5.7) 
This functional form captures the overall time history of the parameter in an effort to account for 
the irreversible nature of the HIFU ablation process. By thresholding  m a x 0, ,X y z t  on the last 
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frame of STBM data, when the entire lesion has formed, a binary mask was generated and 
compared with the mask from the gross lesion on a pixel-by-pixel basis. By varying the 
threshold, receiver operating characteristic (ROC) curve and the accuracy curves were 
constructed. The pixel-by-pixel classification was applied on 24 datasets and overall ROC and 
accuracy curves were generated. The “optimal” threshold is chosen to be the parameter threshold 
value at maximum accuracy.  
5.2.3 Identification of gas bodies: The frame-to-frame echo decorrelation parameter 
F F
  can 
be used to capture rapid changes in successive frames, and hence this parameter is proposed to 
identify any newly-formed or actively moving gas bodies, including any active process involving 
the expansion of the tissue. Because no gas bodies are likely to exist within the tissue prior to the 
initiation of HIFU treatment, any parameter used for classification of gas-body activity should, at 
minimum, not identify gas bodies during the pre-HIFU period. For any given parametric image 
( , , )
F F
y z t , the threshold 
0
F F
  for gas-body identification was chosen to be minimum value of 
F F
  such that 
0
( , , )
F F F F
y z t   for all y and z at all O Nt t , where O Nt  is the time of HIFU 
initiation. After gas bodies were identified, the amount of the displacement of their top most 
pixel from the focal spot was tracked in each frame to evaluate the rate at which the cavity is 
expanding, defined as dynamic expansion rate (ER) of the cavity. A moving-average filter of 
duration 0.08 s was applied to the displacement of gas bodies to remove the artifacts due to tissue 
movements that may have occurred during HIFU. After classifying each lesion as “cavity-
forming” or “non-cavity-forming” based on the existence of macroscopic cavities in gross 
lesions, the expansion rate for each specimen was computed and then a threshold to segregate the 




5.3.1 High Frequency Rapid B-mode Imaging during HIFU ablation 
Figure 5.2 [37] shows an example for HIFU ablation (4.33 MHz center freq., 
2600 W/cm
2
, 77 Hz PRF, 50% duty cycle and 1 s exposure time) illustrating the complex 
dynamic changes in tissue during HIFU exposure involving tissue necrosis and formation of gas 
bodies. With the HIFU beam incident from the left side of the image, the B-mode image after 
HIFU (Figure 5.2B) clearly shows the lesion compared with the image before HIFU (Figure 
5.2A), and matches very well with the gross image of the lesion (Figure 5.2C). The dashed 
vertical lines indicate the lateral boundaries of the short time, B-mode (STBM) window. While 
the spatiotemporal evolution of the lesion can be more readily appreciated in the video playback 
of the STBM frames, the horizontally stacked images are included in Fig. 5.2D for convenient 
representation. Selected frames from Figure 5.2D are enlarged to better show the dynamics of 
HIFU lesion and gas body evolution in detail in Frames 5.2F1–F11. After the HIFU is turned on at 
t =0.02 s, a bright hyperechoic region appeared near the focus after a time delay at t = 0.16 s, 
most likely representing gas-body activity generated by acoustic cavitation and thermally 
induced water vaporization at the 2600 W/cm
2
 intensity [28] and the relatively high frequency of 
the HIFU transducer used in this study. The initiation of gas-body activity is clearly shown 
starting from the left side in Frame 5.2F2 (closer to the HIFU transducer) and then growing in 
subsequent Frames 5.2F3–F4 before filling the entire width of the window by Frame 5.2F6. The 
hyperechoic region appears to grow and expand laterally with respect to the HIFU beam axis 
(Frame 5.2F7). This lateral expansion of the hyperechoic region could be due to the combined 
effects of apparent echo strain resulting from variation in speed of sound at elevated 




Figure 5.2 (A) Grayscale B-mode images (A) before and (B) after HIFU with dash-dotted lines showing 
the location of the Short-Time B-Mode (STBM) window that was used for imaging during HIFU at a 
frame rate of 77 Hz, intensity of 2600 W/cm
2
, 50% duty cycle, and 1 s exposure time. The direction of 
HIFU beam was from left to right. (C) Post-HIFU photograph of lesion and cavity in gross tissue 
specimen. (D) Horizontally-stacked STBM grayscale frames showing the spatiotemporal evolution of the 
lesion in the STBM window. Vertical green dash-dotted lines indicate the times when the HIFU was 
turned on and off. (E) Photograph of lesion and cavity in gross tissue specimen, rescaled to have the same 
spatial scale as Fig. D. The contour on the outer edge of the lesion has been marked (cyan), and the 
location of STBM window lines is shown by the white dashed lines. The dashed yellow lines show 
correspondence between features in ultrasound and optical images. (F) Selected individual STBM 
grayscale frames before (F1), during (F2–F7), and after (F8–F11) application of HIFU. 
 
move downward (away from the imaging transducer), indicating contraction and maybe 
dissipation of the gas bodies (Frames 5.2F8 and 5.2F9) and two weakly echogenic regions 
become visible, separated by a hypoechoic region in between (Figure 5.2D and Frames 5.2F8 
and 5.2F9). These hyperechoic and hypoechoic regions from STBM (indicated by the white 
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vertical dashed lines) correspond well with the tissue necrosis and cavity regions of the gross 
tissue image (Figure 5.2E) (same as Figure 5.2C). Figure 5.2E also highlights the contour (cyan 
line) manually drawn along the outer edge of the lesion to indicate the area of necrosis. 
5.3.2 Lesion Identification 
To construct ROC curves between the post-HIFU frame of STBM data and the gross 
image, we identified a binary mask for the lesion in gross image at the STBM window location. 
As shown by the general block diagram for the procedure (Figure 5.3A [37]), first the area of 
necrosis was indicated manually by the outer edge of the lesion (e.g., cyan contour in Figure 
5.3B) on the gross image of the tissue specimen. Then, to represent the STBM window location 
on gross image, the post-HIFU B-mode image that was registered with the STBM window 
location (white dashed lines in Figure 5.3C) was overlaid on top of gross image to register 
common structural features such as lesion, cavity (if exists), and boundaries of the tissue. After 
registering the STBM window in the gross image (Figure 5.3D), the lesion area was used to 
create a binary mask (Figure 5.3E) for representing the necrosed area (i.e., 1 is necrosed tissue  
 
Figure 5.3 (A) Block diagram of procedure for obtaining the binary mask of lesion in gross image. (B) 
Manually drawn outer edge of the lesion (cyan) in gross image. (C) Registration of STBM window 
location (white dashed lines) in B-mode image. (D) Spotted STBM window location on gross image after 




and 0 is non-necrosed). The proposed parameters defined in Eq. 
Error! Reference source not found. to Error! Reference source not found. along with spectral 
parameters are evaluated on each frame of STBM data. For any given parameter X(y, z, t) 
defined in Eqs. Error! Reference source not found. to Error! Reference source not found., the 
temporal maximum of the parameter was also computed according to  
     m ax 0 0, , m ax , , 0
t
X y z t X y z t t   . (1) 
This functional form captures the overall time history of the parameter in an effort to 
account for the irreversible nature of the HIFU ablation process. By applying a threshold to the 
final frame of
 
 m a x 0, ,X y z t , when the entire lesion has formed, accuracy of the parameter for 
lesion identification at that threshold was determined. By applying this procedure to all the data 
sets, an overall ROC curve was generated for each parameter (Figure 5.4 [37]). The ROC area 
under the curve (AUC), maximum accuracy, optimal threshold at maximum accuracy, 
sensitivity, and specificity from pixel-by-pixel classification for each parameter is shown in 
Table 1. IBSmax and ΔMmax have highest areas under the ROC curve (ROC AUC ~ 0.96). We 
chose to compute IBSmax for subsequent analysis as it had the highest AUC. The maximum 
accuracy in detecting the lesion was obtained at an IBSmax of +12 dB. 
An abrupt increase in IBS was observed when gas bodies were identified by the echo 
decorrelation method and agrees well with a study [20] where cavitation detection showed 
largest changes in IBS associated with cavitation activity. In a study on ex vivo bovine liver [39], 
the AUC ROC for intercept and midband fit in characterizing the lesion reported were 0.71 and 
0.69, respectively, which are comparable to values found  in the current work ( I : 0.737, M : 
0.745), but the values for the corresponding temporal extrema (
m a x
I : 0.903, 
m a x
M : 0.947) in 




Figure 5.4 Comparison of overall ROC curves for several methods in detecting the lesion for all 
specimens (IBSmax: temporal maximum (t.m.) of integrated backscatter, ΔMmax: t.m. of relative change in 
mid-band fit, ΔImax : t.m. of relative change in intercept, 
, m axF F
 : t.m. of frame-to-frame decorrelation, 
, m a xIF
 : t.m. of initial frame decorrelation, and GS: Grayscale) 
 
the usage of ablation time history via the temporal maximum method can increase the 
performance of these parameters for lesion identification. 
Table 5.1. Results from pixel-by-pixel lesion classification for different parameters. 
Parameter AUC Threshold Accuracy Sensitivity Specificity 
IBSmax (dB) 0.96 12.0 0.94 0.76 0.98 
ΔMmax (dB) 0.95 15.8 0.93 0.79 0.97 
ΔImax (dB) 0.91 25.5 0.91 0.68 0.97 
σFF, max 0.93 1.28 0.92 0.66 0.98 
σIF, max 0.91 1.48 0.91 0.57 0.99 
Grayscale (dB) 0.68 0.75 0.84 0.20 0.98 




To check the importance of high imaging frame rate on the performance of 
m a x
IB S  in 
identifying the lesion, the frame rate of each dataset was manually decimated to half the original 
frame rate. Upon generating the 
m a x
IB S  ROC curves of these decimated frame rate datasets, a 
drop in the ROC AUC (area under curve) by 20%, accuracy by 2%, and the sensitivity by 20% 
was observed. The drop is more prominent in the case when frame rate was reduced from 130 Hz 
to 65 Hz than in the case of 77 Hz to 39 Hz indicating that higher frame rate indeed improves the 
lesion identification by capturing faster events. 
5.3.3 Identification and Tracking of Gas Bodies 
As an example, Figure 5.3 shows a series of stacked short time B-mode frames with gas-body 
activity marked in green, as identified by frame-to-frame echo decorrelation method. The top-
most pixel in each frame that is identified as gas-body activity (if there exists one) is represented 
by red dot to track its location in time. Cases where pronounced movement/expansion of the 
tracked gas bodies occurred (Figure 5.5A [37], 2600 W/cm
2
, 77 Hz PRF, 50% duty cycle and 1 s 
exposure time) were well correlated with the existence of macroscopic cavity formation during 
HIFU as shown in gross image (Figure 5.5B), in contrast with minimal movement of gas bodies 
for cases where no observable macroscopic cavity was generated (Figure 5.5C and 5.5D) 
(2600 W/cm
2
, 77 Hz PRF, 50% duty cycle and 0.2 s exposure time). The displacements from the 
center line were tracked and the corresponding expansion rate (ER) of the top-most gas-body 
location was computed. Figure 5.6 [37] shows that the non-cavity datasets have a significantly 
lower ER (0.51 ± 0.21 mm/s, n = 5) compared to the cavity datasets (1.37 ± 0.39 mm/s, n = 19) 
based on a T-test (p < 10
-4
). As a result, a threshold of 0.8 mm/s was chosen to classify those gas 





Figure 5.5. (A) Stacked short-time B-mode (STBM) grayscale frames with marked regions of gas-body 
activity (green pixels) of dataset with macroscopic cavity (data in Figs. 5.2). The top most green pixel in 
each frame is marked by a red dot. Vertical dash-dotted lines indicate the times when the HIFU was 
turned on and off. (B) Gross image of dataset in (A) with lesion contour (cyan) and location of STBM 
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window lines (vertical white dashed lines) (C) STBM grayscale frames with marked regions of gas-body 
activity of dataset without macroscopic cavity (D) its gross image.  (E) Position of uppermost gas-body 
activity in the cavity dataset (Fig. 5.5A), non-cavity dataset (Fig. 5.5C) and their corresponding moving 
average (dashed lines) based on a averaging window of 0.08 s. (F) Expansion rate of gas-body activity 
from numerical derivatives of curves in Fig. 5.5A. 
 
 
Figure 5.6 Expansion rate of non-cavity (n = 5) and cavity (n = 19) datasets with error bars. The selected 
expansion rate threshold (0.8 mm/s) is shown by the dot-dashed horizontal line. 
Using the criteria for identification of lesion and gas bodies, parametrically-labeled 
images were generated retrospectively to demonstrate the feasibility of tracking lesion and gas-
body formation during HIFU exposure. 
5.3.4 Parametric Imaging for Lesion and Gas Body Marking during HIFU Ablation  
For the data of Figure 5.2, Figure 5.7 [37] shows selected grayscale image frames with 
markings for the lesion, gas-body activity, and cavity-formation superimposed (See Media-
Movie 5.1 for the corresponding video). Consecutive frames are separated by white dashed 
vertical lines and others by blue dashed lines. Frame 5.7A1 shows the last frame prior to HIFU 
application, with the early evolution of the lesion (red) after the initiation of gas-body activity 
shown in Frames 5.7A2–A5. The ER of the gas bodies is below the threshold until Frame 5.7A5, 




Figure 5.7 Example of lesion with gas-body activity and cavity formation (2600 W/cm
2
, 77 Hz PRF, 50% 
duty cycle and 1 s exposure time). The time evolution of ablation process is shown at selected times. The 
green frame labels indicate the frames during HIFU exposure. The area of tissue necrosis evaluated using 
the optimal IBSmax threshold of 12 dB is represented in red, gas bodies expanding at less than expansion 
rate threshold (<0.8 mm/s) in green, and gas bodies which crossed expansion rate threshold in blue (≥0.8 
mm/s). The lesion contour in each frame is shown in cyan. 
threshold, indicating the capability of the gas bodies to create a cavity, and reaches a maximum 
ER of 1.36 mm/s at 0.377 s  (Frame 5.7A9). The gas bodies in Frames 5.7A6–A17 are then color 
coded in blue. The gas body expands, and the lesion grows until Frame 5.7A13 when the HIFU is 
turned off. Frames 5.7A14–A16 show a downward movement, representing shrinking and 
dissipation of the gas-body activity. The lesion- marking algorithm covers most of the area of 
lesion contour (cyan curve) determined from the gross lesion, although lesion extent is over-
estimated in the region below the lesion. This overestimation is likely due to reverberation 
artifacts of the backscattered ultrasound from the HIFU-induced gas body, as seen in 
Frames 5.7A10 and 5.7A12. 
5.3.4.1 Effect of PRF  
Figure 5.8 [37] shows an example of a case with HIFU ablation at higher PRF than in that 
for the case in Figure 5.7 (130 Hz vs. 77 Hz) with all other conditions equal. A cavity apparent in 




Figure 5.8 Example of lesion with gas-body activity and cavity formation (2600 W/cm
2
, 130 Hz PRF, 
50% duty cycle and 1 s exposure time). (A) B-mode image after HIFU treatment with location of STBM 
window shown by the dashed vertical lines (white). (B) Image of gross tissue with lesion, manually 
estimated lesion contour (cyan), and location of STBM window (vertical dashed green lines). (C) B-mode 
image with an overlay of predicted lesion (red) using IBSmax in STBM window and manually estimated 
lesion contour (cyan) from gross image. (D) Time evolution of ablation process is shown at selected times 
(see Fig. 5.7 caption for description of colors). 
(Figure 5.8B). The extent of lesion area (red) predicted from STBM data using IBSmax with +12 
dB threshold is overlaid on STBM window of the post-HIFU B-mode image (Figure 5.8C). As 
shown in Figure 5.8D, selected frames from the time evolution of the ablation, higher PRF 
ablation generates less area identified as gas and a smaller cavity size in the gross tissue as 
compared to Figure 5.7. The ER crossed the cavity-formation threshold at 0.492 s (frame 5.8D7), 
reaching a maximum ER of 1.35 mm/s at 0.515 s (frame 8D8), and then dissipation of gas bodies 
occurred after the HIFU was turned off. When the cases with 77 Hz and 130 Hz PRF are 
compared (2600 W/cm
2
, 50% duty cycle), the durations for crossing the ER threshold after HIFU 
was turned on were 0.324 ± 0.090 s (n = 8) and 0.405 ± 0.054 s (n = 4), respectively, although 
the difference was not quite statistically significant (T-test with unequal variances, p = 0.077). 
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The increased delay illustrated in Figure 5.8 as compared to Figure 5.7 suggests that higher PRF 
may result in slower expansion. This slower growth of gas bodies could be the reason for smaller 








n = 4 for 
77 Hz with other conditions 2600 W/cm
2
, 50% duty cycle and 1 s exposure time being same) at 
the end of the ablation as seen in the gross image (Figure 8B).   
5.3.4.2 Effect of Exposure Duration  
Figure 5.9 [37] shows an example of a dataset with lower exposure duration than in 
Figure 5.7 (0.2 s vs. 1.0 s) with all other conditions equal. (See Media-Movie 5.2 for the 
corresponding video). The B-mode image shown in Figure 5.9A does not show any hypoechoic 
regions without the presence of a macroscopic cavity in the lesion (Figure 5.9B). The predicted 
lesion area (red) from STBM data is overlaid on STBM region of post HIFU B-mode image 
(Figure 5.9C). Figure 5.9D shows a composite image that presents the evolution of the ablation 
process with time. Although sudden occurrence of gas bodies (Frame 9D3) and their initial 
activity (Frames 5.9D3–D5) was observed, the short HIFU exposure duration limited the chance 
for the expansion/movement of these gas bodies and formation of a tissue cavity. (At 
Frame 5.9D6 the HIFU was turned off.) Because the ER of the gas bodies did not cross the 
threshold, they remain colored in green. In the datasets with lower HIFU exposure times (with all 
other conditions equal: 2600 W/cm
2
, 77 Hz PRF, 50% duty cycle), the cavity was either absent 
(0.2 s exposure, n = 5) or small (cavity area = 0.066 ± 0.039 mm
2
 for 0.6 s exposure, n = 6) 
compared to Figure 5.7 (cavity area = 0.187 ± 0.064 mm
2
 for 1 s exposure, n = 4). The non-
cavity datasets (all of which were 0.2 s exposure cases and without cavity in the gross images) in 
Fig. 5.6 were used to determine the ER threshold in the model so that no cavity is predicted in 




Figure 5.9 Example of lesion with gas-body activity but without macroscopic cavity formation 
(2600 W/cm
2
, 77 Hz PRF, 50% duty cycle and 0.2 s exposure time). (A) B-mode image after HIFU 
treatment with location of STBM window shown by the dashed vertical lines (white). (B) Image of gross 
tissue with lesion, manually drawn lesion contour (cyan), and location of STBM window (vertical dashed 
green lines). (C) B-mode image with an overlay of predicted lesion (red) using IBSmax in STBM window 
and manually estimated lesion contour (cyan) from gross image. (D) Time evolution of ablation process is 
shown at selected times (see Fig. 5.7 caption for description of colors). 
vs. 1.5 ± 0.3 mm/s) and their time of occurrence (0.44 ± 0.04 s vs. 0.42 ± 0.04 s) were nearly the 
same. However, the total expansion was higher in the cases with longer exposure, resulting in a 
larger cavity size. 
5.4 Discussion 
5.4.1 Lesion Identification 
Integrated backscatter, spectral parameters, and echo decorrelation have been explored in 
estimating the formation of lesion area in previous work and a comparison on each parameter 
was made with the results observed in current paper in the following paragraphs.  
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The changes in integrated backscatter (IBSmax) has been used previously to monitor HIFU 
lesion formation with B-mode RF data acquisition in ex vivo bovine liver [19, 20], although at 
lower imaging frequency of 7.5 MHz when compared to 55 MHz imaging frequency used in the 
current study. The authors observed sudden increases in the apparent width of the lesion midway 
through the exposure period, similar to the results observed at the longer exposure times in the 
current study (e.g., Figure 5.7). A subsequent study with cavitation detection showed that the 
largest changes in IBS were associated with the cavitation activity [20]. In the current study, we 
also observed an abrupt increase in IBS when gas bodies were identified by the echo 
decorrelation method. We showed that the temporal maximum IBS performed better than the 
IBS alone in identifying the extent of the lesion as compared to the final state. However, the 
current method does appear to be affected by reverberation artifacts when extensive gas body 
formation occurs (Figure 5.7, 5.8). 
For the spectral parameters, the M and I  increases observed in lesions induced by 
HIFU of current study are consistent with other studies [21, 40], where an increase in midband fit 
of 6 to 8 dB in lesion over surrounding non-ablated tissue was observed in ex vivo chicken breast 
and rabbit liver. The slope parameter m  in the current study yielded inconsistent results from 
case to case and was not useful for lesion identification (see Table 5.1). Spectral parameters have 
also been computed to characterize lesions induced by RF ablation in ex vivo bovine liver [39]. 
The AUC ROC for intercept and midband fit were reported to be 0.71 and 0.69, respectively, 
which are comparable to values found in the current work ( I : 0.74 ± 0.13, M : 0.75 ± 0.14), 
but worse than values for the corresponding temporal extrema (
m a x
I : 0.91 ± 0.06, 
m a x
M : 
0.95 ± 0.04) in Table 5.1. The improved ROC performance of ΔMmax and ΔImax suggest that the 
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usage of ablation time history via the temporal maximum method can increase the performance 
of these parameters for lesion identification. 
In the current study, 
m a x
IB S  showed slightly better performance in lesion identification 
(ROC AUC 0.96 ± 0.02) as compared to 
, m axF F
  (ROC AUC 0.93 ± 0.05), although the 
performance of 
, m axF F
  was comparable to the previous study [22, 41]. The difference in the 
performance of 
m a x
IB S  in the current study from [22] could be due to higher bandwidth, the 
increased backscatter due to HIFU-induced gas body formation, and higher imaging rate (77–130 
Hz vs 50 Hz), which might allow 
m a x
IB S  to capture faster activities and events.  
The temporal extrema of the parameters uses the time history of ablation via. Eq. (1) and 
a comparison between the performance of the parameters with and without temporal extrema 
shown in Table 1 shows the value added by using the time history of ablation in the lesion 
detection process. For all of the parameters, nearly a 20% increase in both ROC AUC and 
accuracy were observed when the time history of ablation was used. 
To check the importance of high imaging frame rate on the performance of 
m a x
IB S  in 
identifying the lesion, the frame rate of each dataset was manually decimated to half the original 
frame rate. Upon generating the 
m a x
IB S  ROC curves of these decimated frame rate datasets, a 
drop in the ROC AUC (area under curve) by 20%, accuracy by 2%, and the sensitivity by 20% 
was observed. The drop is more prominent in the case when frame rate was reduced from 130 Hz 
to 65 Hz than in the case of 77 Hz to 39 Hz indicating that higher frame rate indeed improves the 
lesion identification by capturing faster events. 
5.4.2 Gas Body Identification  
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Because of the gas-body formation significantly enhances echogenicity in the lesion 
region and 
, m axF F
  performed well in the identification of lesion extent, we proposed the use of 
frame-to-frame echo decorrelation 
F F
 as a means to identify newly formed and expanding gas-
body activity. (The method will not capture pre-existing static gas bodies.) Based on the 
identified gas bodies, expansion rate information of the gaseous region was used to predict the 
occurrence of the macroscopic cavity.  
The effects of various HIFU exposure parameters on the expansion rate of gaseous 
regions and the time to reach the threshold for macroscopic cavity formation were examined in 
this study. As described in the Sec. D, at higher PRF (130 Hz vs. 77 Hz) with other conditions 
equal, slower growth rate and smaller cavity size were observed. This is likely due to the shorter 
duration of each pulse with the increased duty cycle. With reduced energy input in tissue during 
each ultrasound pulse, higher PRF reduced the likelihood of gas-body initiation and heating, 
thereby lowering the expansion rate. Consistent with this observation, in the data sets with lower 
duty cycle (25%, all other conditions equal: 2600 W/cm
2
, 77 Hz PRF, 1 s exposure), a lower 
value of the maximum ER of 0.93 ± 0.02 mm/s (n = 2) was observed, compared to 
1.5 ± 0.3 mm/s (n = 4) in the cases with 50% duty cycle. There was also a longer delay 
(0.68 ± 0.25 s) in reaching the maximum ER compared to that in the cases with 50% duty cycle 
(0.36 ± 0.12 s). The lower duty cycle exposure also resulted in smaller cavity sizes (cavity area = 
0.013 ± 0.0014 mm
2
 at 25% duty cycle vs. cavity area = 0.187 ± 0.064 mm
2 
at 50% duty cycle) 
in the gross images at the end of ablation. These observations indicate that pulsed HIFU 
exposure parameters may be optimized to control gas-body activity in HIFU ablation.  
Although simulating the in-vivo condition was not the goal of our study, the concept of 
our technique should be applicable for in-vivo application and the technique can be translated 
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after appropriate modification of the experimental setup to improve the speed of signal 
processing and instrument configuration.  For example, integrating the imaging probe with the 
HIFU transducer collinearly would be a feasible approach. Second, gating strategies can be 
implemented to account for the cardiac tissue movements due to the beating heart and breathing.  
To implement the proposed method of lesion estimation for in-vivo applications, the threshold 
for IBS parameter needs to be predetermined since the effect of blood perfusion on lesion 
estimation using IBS was not studied in this paper. By taking a similar approach to construct 
“training data sets,” non-invasive methods like MRI can be used to obtain lesion maps, which 
then can be used with IBS maps to construct ROC curves to determine the threshold. Although 
obtaining histology sections can provide the gold standard, it is invasive and may not be a viable 
way in general to obtain lesion map. Alternatively, in vitro results may be used as the first order 
of approximation, but experimental validation must be performed. Other challenges include the 
possibility that the threshold for lesion detection might be patient-dependent and tissue specific 
as different tissue types might have different tissue properties (ex: attenuation, thermal 
diffusivity) and will have different echogenic properties. Because the generation of macroscopic 
cavities in bulk tissue volumes may not be desired in achieving controlled HIFU ablation of 
cardiac tissue, identification of the precursors of such events along with the estimated extent of 
the lesion can be used as a feedback control to adjust HIFU exposure parameters during 
treatment.  
In contrast to our M-mode study [42], which probed rapidly (1 kHz PRF) at a single line 
in space, the STBM method allows for a better study of the spatiotemporal development of 
lesion, gas body generation and its movement in 2D, albeit at a slower rate (77-130 Hz frame 
rate). Because acoustic radiation force from the HIFU transducer can cause a small amount of 
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motion in the direction of the HIFU beam, interpretation of the acquired M-mode data can be 
complicated due to the spatial shifting of the tissue and lesion. With the larger STBM spatial 
window, this factor is much less important. In addition, the current study uses 2D spatial 
functions to compute the IBS and echo decorrelation parameters as opposed to 1D spatial 
functions in M-mode study, and that difference may have improved the lesion detection accuracy 
(area under curve of ROC: 0.96 vs. 0.91). Both the STBM and M-mode studies independently 
obtained same optimal IBSmax threshold (12 dB) for identifying the lesion extent even with 
differences in exposure conditions. However, the current study has been able to use the acquired 
2D spatiotemporal information for prediction of macroscopic cavity formation and been able to 
investigate the effect of more HIFU ablation parameters (duty cycle, PRF, exposure duration) on 
ablation outcomes such as lesion width, time of occurrence of the gas bodies and their maximum 
expansion rate (ER), and the presence of macroscopic cavities and their size. 
5.4.3 Limitations 
 In this study, lesion classification relied on matching the plane of B-mode imaging with 
the sectioning plane of the tissue lesion. Hence, small errors due to this mismatch in B-mode and 
gross tissue planes might occur in the estimation of lesion formation. Fixation and embedding of 
the tissue (which will be used in future study) could allow for more precise sectioning but this 
process also introduces potential spatial distortion due to the tissue preparation process. The 
threshold of IBSmax in estimating the lesion extent will probably be affected by flow perfusion 
and hence may be different for future study from the threshold obtained in preliminary results. 
This dependence on the perfusion can be accounted by determining its own threshold. The 
acoustic radiation force can cause some tissue motion at the focal spot of HIFU probe during the 
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treatment process; however, this effect will be minimized by physically securing the tissue in 
place during ablation.  
5.5 Conclusion 
In this study, we compared the performance of several RF-based techniques using high-
frequency, short-time B-mode imaging. We established a threshold to identify lesion area based 
on the time history of integrated backscatter and evaluated the performance of these methods 
using ROC curves. The temporal maximum of the integrated backscatter IBSmax at 12 dB 
threshold was determined to best map lesion induced by HIFU ablation with good accuracy. In 
addition, we demonstrated the use of frame-to-frame echo decorrelation to identify the rapidly-
changing hyperechoic regions observed in the B-mode frames during ablation that are likely to 
be HIFU-induced gas-body activities. We evaluated the cavity expansion rate to develop a 
criterion for predicting the occurrence of a macroscopic cavity during ablation. The use of high 
imaging frame rate and high spatial resolution allowed for the detailed tracking of the time 
history of ablation in lesion detection and cavity formation. 
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Conclusions and Future Work 
 
 
In this thesis, high resolution ultrasound was used as an imaging modality for tissues and 
tissue engineered constructs to monitor the 2D/3D structural changes and to characterize the 
tissue changes either induced by HIFU ablation or by cell differentiation. A working application 
of spectral ultrasound imaging (SUSI) technique was developed and verified with polybead 
phantoms (Chapter 2). The technique is then used to assess the amount of mineral content in 
acellular constructs (Chapter 3). The development changes of MC3t3-cell constructs which 
include net cell proliferation/apoptosis, matrix and mineral production was studied in Chapter 4. 
High frequency and high frame rate B-mode imaging was used to assess the HIFU ablation 
process to characterize the lesion extent and the gas body activities in Chapter 5. 
In general, this assessment technique will be helpful in non-destructive characterization 
and monitoring of the tissue samples in lab and for in-vivo applications in small animals. But due 
to the shallow imaging regions owing to higher attenuation at high imaging frequencies, this 
technique might be limited to fewer specific applications such as dermatology in humans. Some 
of the very specific research that can be investigated to realize the proposed SUSI technique in 
aforementioned applications are discussed below. 
6.1 Spectral ultrasound Imaging 
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 In the current approach, 1D fourier spectrum of the high frequency ultrasound signal 
from tissues and tissue engineered constructs were investigated to estimate the scatterer 
properties. Very close estimations were obtained for scatterer diameter of 6-25 µm including 
their concentration estimations. 
 Similar approaches as that of SUSI were employed to quantitatively characterize freshly 
dissected lymph nodes of cancer patients [1]. In their quantitative ultrasound method, 
backscattered signals were processed using 3D cylindrical regions of interest to yield parameter 
estimates associated with tissue microstructure. The estimated intercept and slope were used to 
differentiate a metastatic node from a non-metastatic lymph node by setting a size threshold 
using the Gaussian form factor. These results indicate that quantitative ultrasound methods were 
able to classify the nodes that either are completely metastatic or are completely free of 
metastatic tissue. 
One of the advantage of the study in the current thesis over the above study is in its 
ability to resolve the smaller scatterer sizes (6-25 µm) as opposed to > 20 µm due to the high 
frequency ultrasound imaging employed in the current thesis (55 MHz as opposed to 25.6 MHz). 
With 55 MHz ultrasound imaging system can be used to employ similar technique on a 3D 
segment of the tissue by taking the 3D fourier transform on the backscattered 3D RF data, which 
might have even improved estimations.  
6.2 Cell Cytoskeleton Study 
The contribution of the cell organelles towards the spectrum of the ultrasound signal can 
be investigated for detailed understanding of SUSI. The contribution from actin filaments, 
microtubules and nuclei [2, 3] in the ultrasound spectrum and on the corresponding spectral 
parameters can be used to assess different cell types, their longitudinal growth and their 
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differentiation processes. Each cell organelle investigation should be verified with biochemical 
assays to conclude the observations. 
6.3 Differentiation Study 
 MC3t3 cell net proliferation/apoptosis and their differentiation processes in an in-vitro 
petri-dish were studied in the current thesis. Cell size, concentration and calcium mineral 
estimates were estimated with good accuracy using spectral ultrasound imaging. The 
effectiveness of the spectral ultrasound imaging in identifying the differentiation process can be 
investigated when the constructs are implanted in an in-vivo animal model. The non-destructive 
and non-invasive evaluation of the implanted scaffolds would benefit from the ability to monitor 
the cellular changes during the differentiation process at the implant site without the need for 
periodic animal sacrifice and explant analysis. This technique may allow the tissue engineers to 
sequentially evaluate the progress of tissue construct development process in-vivo. 
6.4 HIFU Ablation Monitoring 
RF data acquired from high-frequency, short-time B-mode imaging, a threshold to 
identify lesion area was established based on the time history of integrated backscatter. In 
addition, frame-to-frame echo decorrelation was proposed to identify the rapidly-changing 
hyperechoic regions observed in the B-mode frames during ablation that are likely to be HIFU-
induced gas-body activities. Based on this approach, cavity expansion rate was evaluated to 
develop a criterion for predicting the occurrence of a macroscopic cavity at the end of ablation. 
This criterion could be useful in situations where monitoring is needed to prevent macroscopic 
cavity formation in the HIFU treatment process.  
To adapt the method into practical application, it can be implemented in HIFU treatment 
of atrial fibrillation in ex-vivo rabbit heart for real-time monitoring and feedback control in order 
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to achieve the desired ablation outcome as future study. For a given PRF of HIFU ablation, the 
RF data of each frame can be acquired during off period of HIFU and its processing to produce 
the parametric image representing the lesion extent, any occurrence of the gas bodies and their 
expansion rate can be done during the on period of HIFU. Based on the desired ablation 
outcome, if either the lesion extent estimated by IBSmax in this frame is the desired area or if the 
generated gas bodies are expanding at a rate which is capable of forming a macroscopic cavity 
then a feedback control will be activated to either end the ablation or to reduce the intensity of 
the HIFU exposure for desired ablation outcome.  
The extent of the lesion created during the ablation can be monitored using IBSmax and 
can be verified with histological sections. The performance of IBSmax is expected to match with 
AUC, accuracy, sensitivity and specificity values in Table 6.1. Also, the evolution of the 
estimated lesion extent as it forms can be studied with online changes in electrophysiological 
properties of lesion and normal tissue obtained from fluorescence optical imaging camera. Any 
occurrence of the bubbles, as detected by frame-to-frame echo decorrelation can be expected to 
match with bubble detection using passive cavitation method and at the end of the ablation, no 
macroscopic cavities can be expected in the tissue when the feedback control is implemented to 
avoid the cavity formation based on expansion rate of the bubbles.   
6.5 Acoustic Radiation Force Imaging 
In its noninvasive applications, elastography has been typically used to determine local 
tissue strain through the use of externally applied mechanical compression [4, 5]. Focused 
ultrasound can be used to apply localized radiation force to small volumes of tissue for short 
durations (less than 1 ms) and the resulting tissue displacements can be mapped using ultrasonic 
correlation-based methods [6-8]. The tissue displacements are inversely proportional to the 
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stiffness of the tissue and thus, a stiffer region of tissue exhibits smaller displacements than a 
more compliant region. Due to the short duration of the force application, this method provides 
information about the mechanical impulse response of the tissue, which reflects variations in 
tissue viscoelastic characteristics. With known strain maps of the tissue from the correlation-
based methods and known input radiation force, elastic modulus of the specimen can be 
estimated, which needs to be validated with mechanical compressive testing. 
  Thus acoustic radiation force imaging can be used as a non-destructive and non-invasive 
tool to estimate the elastic properties of the tissues and tissue constructs in real-time. Due to its 
non-invasive nature, tissue scaffolds can be implanted in an in-vivo animal and their remodeling 
over time can be studied by studying the elastic properties of the implant site. Also, ARFI 
imaging has many potential clinical applications, including detecting and characterizing a wide 
variety of soft tissue lesions, and identifying and characterizing atherosclerosis, plaque and 
thromboses. 
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